www.citeline.com Open in urlscan Pro
2606:4700::6812:12aa Public Scan

Go To Rescan
Add Verdict Report

URL:
https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&...
Submission: On October 05 via manual (October 5th 2023, 3:08:09 am UTC) from US — Scanned from DE

Summary HTTP 149 Redirects Links 9 Behaviour Indicators

Summary

This website contacted 19 IPs in 3 countries across 15 domains to perform 149 HTTP transactions. The main IP is 2606:4700::6812:12aa, located in United States and belongs to CLOUDFLARENET, US. The main domain is www.citeline.com.
TLS certificate: Issued by E1 on August 7th 2023. Valid for: 3 months.

This is the only time www.citeline.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

	IP Address	AS Autonomous System
27	2606:4700::68... 2606:4700::6812:12aa	13335 (CLOUDFLAR...) (CLOUDFLARENET)
4	2a00:1450:400... 2a00:1450:4001:831::2004	15169 (GOOGLE) (GOOGLE)
1	184.25.216.9 184.25.216.9	16625 (AKAMAI-AS) (AKAMAI-AS)
2	2a03:2880:f08... 2a03:2880:f083:9:face:b00c:0:3	32934 (FACEBOOK) (FACEBOOK)
1	2a00:1450:400... 2a00:1450:4001:830::2008	15169 (GOOGLE) (GOOGLE)
6	2a00:1450:400... 2a00:1450:4001:828::2003	15169 (GOOGLE) (GOOGLE)
12	2606:4700::68... 2606:4700::6812:83ec	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	23.53.43.147 23.53.43.147	20940 (AKAMAI-ASN1) (AKAMAI-ASN1)
2	35.201.112.186 35.201.112.186	396982 (GOOGLE-CL...) (GOOGLE-CLOUD-PLATFORM)
1	2a03:2880:f17... 2a03:2880:f176:84:face:b00c:0:25de	32934 (FACEBOOK) (FACEBOOK)
1	2606:4700:440... 2606:4700:4400::ac40:9b77	13335 (CLOUDFLAR...) (CLOUDFLARENET)
1	35.186.194.58 35.186.194.58	15169 (GOOGLE) (GOOGLE)
1	2a00:1450:400... 2a00:1450:4001:82b::2003	15169 (GOOGLE) (GOOGLE)
2	2a02:26f0:350... 2a02:26f0:3500:16::215:149b	20940 (AKAMAI-ASN1) (AKAMAI-ASN1)
82	2600:9000:206... 2600:9000:206f:6c00:2:53b2:240:93a1	16509 (AMAZON-02) (AMAZON-02)
4 4	2620:1ec:21::14 2620:1ec:21::14	8068 (MICROSOFT...) (MICROSOFT-CORP-MSN-AS-BLOCK)
1	13.107.42.14 13.107.42.14	8068 (MICROSOFT...) (MICROSOFT-CORP-MSN-AS-BLOCK)
1	151.101.130.137 151.101.130.137	54113 (FASTLY) (FASTLY)
3	185.221.87.23 185.221.87.23	54113 (FASTLY) (FASTLY)
149	19

27 2606:4700::6812:12aa (United States)

ASN13335 (CLOUDFLARENET, US)

www.citeline.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 2a00:1450:4001:831::2004 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.google.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 184.25.216.9 (Frankfurt am Main, Germany)

ASN16625 (AKAMAI-AS, US)
PTR: a184-25-216-9.deploy.static.akamaitechnologies.com

img06.en25.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a03:2880:f083:9:face:b00c:0:3 (Frankfurt am Main, Germany)

ASN32934 (FACEBOOK, US)

connect.facebook.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:830::2008 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.googletagmanager.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

6 2a00:1450:4001:828::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.gstatic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

12 2606:4700::6812:83ec (United States)

ASN13335 (CLOUDFLARENET, US)

cdn.cookielaw.org	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 23.53.43.147 (Frankfurt am Main, Germany)

ASN20940 (AKAMAI-ASN1, NL)
PTR: a23-53-43-147.deploy.static.akamaitechnologies.com

images.info.citeline.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 35.201.112.186 (Kansas City, United States)

ASN396982 (GOOGLE-CLOUD-PLATFORM, US)
PTR: 186.112.201.35.bc.googleusercontent.com

edge.fullstory.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a03:2880:f176:84:face:b00c:0:25de (Frankfurt am Main, Germany)

ASN32934 (FACEBOOK, US)

www.facebook.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2606:4700:4400::ac40:9b77 (United States)

ASN13335 (CLOUDFLARENET, US)

geolocation.onetrust.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 35.186.194.58 (Kansas City, United States)

ASN15169 (GOOGLE, US)
PTR: 58.194.186.35.bc.googleusercontent.com

rs.fullstory.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:82b::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

fonts.gstatic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a02:26f0:3500:16::215:149b (Frankfurt am Main, Germany)

ASN20940 (AKAMAI-ASN1, NL)

snap.licdn.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

82 2600:9000:206f:6c00:2:53b2:240:93a1 (United States)

ASN16509 (AMAZON-02, US)

cdn.linkedin.oribi.io	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 2620:1ec:21::14 (United States) 4 redirects

ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US)

px.ads.linkedin.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
www.linkedin.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 13.107.42.14 (United States)

ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US)

px4.ads.linkedin.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 151.101.130.137 (United States)

ASN54113 (FASTLY, US)

js-agent.newrelic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 185.221.87.23 (Ireland)

ASN54113 (FASTLY, US)

bam.eu01.nr-data.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

	Apex Domain Subdomains	Transfer
82	oribi.io cdn.linkedin.oribi.io — Cisco Umbrella Rank: 2079	29 KB
28	citeline.com www.citeline.com images.info.citeline.com	2 MB
12	cookielaw.org cdn.cookielaw.org — Cisco Umbrella Rank: 635	148 KB
7	gstatic.com www.gstatic.com fonts.gstatic.com	622 KB
5	linkedin.com 4 redirects px.ads.linkedin.com — Cisco Umbrella Rank: 830 www.linkedin.com — Cisco Umbrella Rank: 951 px4.ads.linkedin.com — Cisco Umbrella Rank: 7048	6 KB
4	google.com www.google.com — Cisco Umbrella Rank: 11	36 KB
3	nr-data.net bam.eu01.nr-data.net — Cisco Umbrella Rank: 10328	1 KB
3	fullstory.com edge.fullstory.com — Cisco Umbrella Rank: 4319 rs.fullstory.com — Cisco Umbrella Rank: 4018	69 KB
2	licdn.com snap.licdn.com — Cisco Umbrella Rank: 1593	9 KB
2	facebook.net connect.facebook.net — Cisco Umbrella Rank: 229	88 KB
1	newrelic.com js-agent.newrelic.com — Cisco Umbrella Rank: 969	28 KB
1	onetrust.com geolocation.onetrust.com — Cisco Umbrella Rank: 958	295 B
1	facebook.com www.facebook.com — Cisco Umbrella Rank: 109	185 B
1	googletagmanager.com www.googletagmanager.com — Cisco Umbrella Rank: 111	87 KB
1	en25.com img06.en25.com — Cisco Umbrella Rank: 100005	14 KB
149	15

	Domain	Requested by
82	cdn.linkedin.oribi.io	www.citeline.com
27	www.citeline.com	www.citeline.com
12	cdn.cookielaw.org	www.citeline.com
6	www.gstatic.com	www.citeline.com www.google.com www.gstatic.com
4	www.google.com	www.citeline.com www.google.com
3	bam.eu01.nr-data.net	www.citeline.com
3	px.ads.linkedin.com	3 redirects
2	snap.licdn.com	www.citeline.com
2	edge.fullstory.com	www.citeline.com
2	connect.facebook.net	www.citeline.com
1	js-agent.newrelic.com	www.citeline.com
1	px4.ads.linkedin.com	www.citeline.com
1	www.linkedin.com	1 redirects
1	fonts.gstatic.com	www.google.com
1	rs.fullstory.com	www.citeline.com
1	geolocation.onetrust.com	www.citeline.com
1	www.facebook.com	www.citeline.com
1	images.info.citeline.com	www.citeline.com
1	www.googletagmanager.com	www.citeline.com
1	img06.en25.com	www.citeline.com
149	20

This site contains links to these domains. Also see Links.

Domain
skipta.com
www.linkedin.com
twitter.com
www.youtube.com
apply.workable.com
www.norstella.com
cookiepedia.co.uk
www.onetrust.com

Subject Issuer	Validity	Valid
citeline.com E1	`2023-08-07` - `2023-11-05`	3 months	crt.sh
www.google.com GTS CA 1C3	`2023-09-18` - `2023-12-11`	3 months	crt.sh
*.en25.com DigiCert TLS RSA SHA256 2020 CA1	`2023-05-21` - `2024-05-20`	a year	crt.sh
*.facebook.com DigiCert SHA2 High Assurance Server CA	`2023-07-14` - `2023-10-12`	3 months	crt.sh
*.google-analytics.com GTS CA 1C3	`2023-09-18` - `2023-12-11`	3 months	crt.sh
*.gstatic.com GTS CA 1C3	`2023-09-18` - `2023-12-11`	3 months	crt.sh
cookielaw.org Cloudflare Inc ECC CA-3	`2023-04-01` - `2024-03-31`	a year	crt.sh
images.information.chemistanddruggist.co.uk R3	`2023-09-27` - `2023-12-26`	3 months	crt.sh
edge.fullstory.com GTS CA 1D4	`2023-09-18` - `2023-12-17`	3 months	crt.sh
onetrust.com Cloudflare Inc ECC CA-3	`2022-12-13` - `2023-12-13`	a year	crt.sh
rs.fullstory.com GTS CA 1D4	`2023-09-13` - `2023-12-12`	3 months	crt.sh
*.google.com GTS CA 1C3	`2023-09-18` - `2023-12-11`	3 months	crt.sh
snap.licdn.com DigiCert SHA2 Secure Server CA	`2023-02-01` - `2024-01-31`	a year	crt.sh
linkedin.oribi.io Amazon RSA 2048 M01	`2023-06-08` - `2024-07-07`	a year	crt.sh
js-agent.newrelic.com GlobalSign Atlas R3 DV TLS CA 2023 Q2	`2023-04-13` - `2024-05-14`	a year	crt.sh
*.eu01.nr-data.net DigiCert TLS RSA SHA256 2020 CA1	`2022-11-18` - `2023-12-19`	a year	crt.sh

This page contains 3 frames:

Primary Page: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Frame ID: DEADAADCC8EB552739A7CFA97FEA1A68
Requests: 140 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcGZr0mAAAAAEujkAfXWCr8dQJBU2ty4sQmu-e4&co=aHR0cHM6Ly93d3cuY2l0ZWxpbmUuY29tOjQ0Mw..&hl=en&v=lLirU0na9roYU3wDDisGJEVT&theme=light&size=normal&cb=6z5co1sy9x1j
Frame ID: 89CB6C321185381C4690A2702AA99B93
Requests: 8 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/bframe?hl=en&v=lLirU0na9roYU3wDDisGJEVT&k=6LcGZr0mAAAAAEujkAfXWCr8dQJBU2ty4sQmu-e4
Frame ID: 8975014E47342889330E71F122580BEC
Requests: 3 HTTP requests in this frame

Screenshot
Live screenshot

Full Image

Page Title

TrialScope Intelligence | CitelineBack ButtonSearch IconFilter Icon

Detected technologies

Facebook (Widgets) Expand

Overall confidence: 100%
Detected patterns

//connect\.facebook\.([a-z]+)/[^/]*/[a-z]*\.js

Google Tag Manager (Tag Managers) Expand

Overall confidence: 100%
Detected patterns

googletagmanager\.com/gtm\.js

Linkedin Insight Tag (Analytics) Expand

Overall confidence: 100%
Detected patterns

snap\.licdn\.com/li\.lms-analytics/insight\.min\.js

OneTrust (Cookie compliance) Expand

Overall confidence: 100%
Detected patterns

cdn\.cookielaw\.org
otSDKStub\.js

reCAPTCHA (Captchas) Expand

Overall confidence: 100%
Detected patterns

/recaptcha/api\.js

Page Statistics

149
Requests

99 %
HTTPS

63 %
IPv6

15
Domains

20
Subdomains

19
IPs

3
Countries

3563 kB
Transfer

7315 kB
Size

17
Cookies

9 Outgoing links

These are links going to different origins than the main page.

URL: https://skipta.com/
Title: HCP Marketing Solutions

Search URL Search Domain Scan URL

URL: https://www.linkedin.com/company/citeline

Search URL Search Domain Scan URL

URL: https://twitter.com/citeline

Search URL Search Domain Scan URL

URL: https://www.youtube.com/@CitelineYouTube/featured

Search URL Search Domain Scan URL

URL: https://apply.workable.com/citeline/?lng=en
Title: Careers

Search URL Search Domain Scan URL

URL: https://www.norstella.com/privacy-notice/
Title: Privacy Policy

Search URL Search Domain Scan URL

URL: https://www.norstella.com/
Title: Norstella

Search URL Search Domain Scan URL

URL: https://cookiepedia.co.uk/giving-consent-to-cookies
Title: More information

Search URL Search Domain Scan URL

URL: https://www.onetrust.com/products/cookie-consent/

Search URL Search Domain Scan URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 144

https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=4341164&time=1696475284671&url=https%3A%2F%2Fwww.citeline.com%2Fen%2Ftrialscope-intelligence%3Futm_campaign%3DCL-TSCOPEDISC-2309-Global-trialscope%2520intelligence-new%26utm_source%3DEloqua%26utm_medium%3DEmail%26utm_content%3D2023-09-Trialscope-Intelligence-Email2%26utm_term%3DExpert%2520insights%2520on%2520clinical%2520trial%2520disclosure%2520compliance%26elqTrackId%3DACA582E5838277658255B36B64FB5865%26elq%3D3440d3db64a641bda4bb65901ae37600%26elqaid%3D5709%26elqat%3D1%26elqCampaignId%3D425&tm=gtmv2 HTTP 302
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=4341164&time=1696475284671&url=https%3A%2F%2Fwww.citeline.com%2Fen%2Ftrialscope-intelligence%3Futm_campaign%3DCL-TSCOPEDISC-2309-Global-trialscope%2520intelligence-new%26utm_source%3DEloqua%26utm_medium%3DEmail%26utm_content%3D2023-09-Trialscope-Intelligence-Email2%26utm_term%3DExpert%2520insights%2520on%2520clinical%2520trial%2520disclosure%2520compliance%26elqTrackId%3DACA582E5838277658255B36B64FB5865%26elq%3D3440d3db64a641bda4bb65901ae37600%26elqaid%3D5709%26elqat%3D1%26elqCampaignId%3D425&tm=gtmv2&cookiesTest=true HTTP 302
https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D4341164%26time%3D1696475284671%26url%3Dhttps%253A%252F%252Fwww.citeline.com%252Fen%252Ftrialscope-intelligence%253Futm_campaign%253DCL-TSCOPEDISC-2309-Global-trialscope%252520intelligence-new%2526utm_source%253DEloqua%2526utm_medium%253DEmail%2526utm_content%253D2023-09-Trialscope-Intelligence-Email2%2526utm_term%253DExpert%252520insights%252520on%252520clinical%252520trial%252520disclosure%252520compliance%2526elqTrackId%253DACA582E5838277658255B36B64FB5865%2526elq%253D3440d3db64a641bda4bb65901ae37600%2526elqaid%253D5709%2526elqat%253D1%2526elqCampaignId%253D425%26tm%3Dgtmv2%26cookiesTest%3Dtrue%26liSync%3Dtrue HTTP 302
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=4341164&time=1696475284671&url=https%3A%2F%2Fwww.citeline.com%2Fen%2Ftrialscope-intelligence%3Futm_campaign%3DCL-TSCOPEDISC-2309-Global-trialscope%2520intelligence-new%26utm_source%3DEloqua%26utm_medium%3DEmail%26utm_content%3D2023-09-Trialscope-Intelligence-Email2%26utm_term%3DExpert%2520insights%2520on%2520clinical%2520trial%2520disclosure%2520compliance%26elqTrackId%3DACA582E5838277658255B36B64FB5865%26elq%3D3440d3db64a641bda4bb65901ae37600%26elqaid%3D5709%26elqat%3D1%26elqCampaignId%3D425&tm=gtmv2&cookiesTest=true&liSync=true HTTP 302
https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=4341164&time=1696475284671&url=https%3A%2F%2Fwww.citeline.com%2Fen%2Ftrialscope-intelligence%3Futm_campaign%3DCL-TSCOPEDISC-2309-Global-trialscope%2520intelligence-new%26utm_source%3DEloqua%26utm_medium%3DEmail%26utm_content%3D2023-09-Trialscope-Intelligence-Email2%26utm_term%3DExpert%2520insights%2520on%2520clinical%2520trial%2520disclosure%2520compliance%26elqTrackId%3DACA582E5838277658255B36B64FB5865%26elq%3D3440d3db64a641bda4bb65901ae37600%26elqaid%3D5709%26elqat%3D1%26elqCampaignId%3D425&tm=gtmv2&cookiesTest=true&liSync=true&e_ipv6=AQLpDd5wQM1eogAAAYr9zoewTirAl50dyoSwgFW74ZqicnQv1hRr7sf_WOIsSceGhh0j9FE

149 HTTP transactions
2 data transactions

Method
Protocol Status Resource
Path Size
x-fer Time
Latency Type
MIME-Type IP
Location

GET
H2 200 Primary Request trialscope-intelligence Show response
www.citeline.com/en/ 227 KB
37 KB 720ms
612ms Document
text/html 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

4176dea42d340993054df0acaef4e630c4235584f0c1df0fddb49b53212c538d

Security Headers

Name	Value
X-Frame-Options	SAMEORIGIN

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36
accept-language: de-DE,de;q=0.9

Response headers

cache-control: no-cache, no-store
cf-cache-status: DYNAMIC
cf-ray: 81127530294c8ff8-FRA
content-encoding: gzip
content-type: text/html; charset=utf-8
date: Thu, 05 Oct 2023 03:08:02 GMT
expires: -1
pragma: no-cache
server: cloudflare
vary: Accept-Encoding
x-frame-options: SAMEORIGIN

GET
H2 200 styles.css
www.citeline.com/dist/css/ 408 KB
76 KB 579ms
578ms Stylesheet
text/css 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://www.citeline.com/dist/css/styles.css?v=638289055950845756
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 8f5bae6d9ab1647e2db3943e6f65bd8a516fce7c25ad6cf9ddc2298715610085

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
cf-cache-status: MISS
last-modified: Tue, 29 Aug 2023 11:33:15 GMT
server: cloudflare
etag: "3c3781996cdad91:0"
vary: Accept-Encoding
content-type: text/css
cache-control: public, max-age=14400
cf-ray: 811275342b5c8ff8-FRA
expires: Thu, 05 Oct 2023 07:08:03 GMT

GET
H2 200 citeline_logo_white-svg.svg
www.citeline.com/-/media/images/logos/ 7 KB
2 KB 439ms
439ms Image
image/svg+xml 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.citeline.com/-/media/images/logos/citeline_logo_white-svg.svg?la=en&hash=BDA3BA5673AFBC184B10F6571EA05532
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 66da8870d4031538e2fe22d26756839203d792798abfc0c570f068779bbfaa81

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:02 GMT
content-encoding: gzip
cf-cache-status: MISS
last-modified: Fri, 14 Jul 2023 15:36:54 GMT
server: cloudflare
vary: Accept-Encoding
content-type: image/svg+xml
cache-control: public, max-age=604800
content-disposition: inline; filename="Citeline_Logo_white-svg.svg"
cf-ray: 811275342b5d8ff8-FRA
expires: Thu, 12 Oct 2023 03:08:02 GMT

GET
H2 200 citeline_logo-svg.svg
www.citeline.com/-/media/images/logos/ 7 KB
2 KB 440ms
439ms Image
image/svg+xml 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.citeline.com/-/media/images/logos/citeline_logo-svg.svg?la=en&hash=2A27F15A821FF6AAD321A63723259A7A
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 086d132722616ee7d36adadb0b302410dab25bddb2773683978f9127df978ae6

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
cf-cache-status: MISS
last-modified: Thu, 20 Jul 2023 19:11:50 GMT
server: cloudflare
vary: Accept-Encoding
content-type: image/svg+xml
cache-control: public, max-age=604800
content-disposition: inline; filename="Citeline_Logo-svg.svg"
cf-ray: 81127537dd3d8ff8-FRA
expires: Thu, 12 Oct 2023 03:08:03 GMT

GET
H2 200 citeline--sticky2x.svg
www.citeline.com/-/media/images/logos/ 6 KB
2 KB 445ms
445ms Image
image/svg+xml 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.citeline.com/-/media/images/logos/citeline--sticky2x.svg?la=en&hash=371463074FC9CB0FBF4FA15984A384C9
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 1dc45b7f92b7971aa8b7befa967a286e1b3812b23ef1287cc2823fcc5640959e

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
cf-cache-status: MISS
last-modified: Thu, 20 Jul 2023 18:34:11 GMT
server: cloudflare
vary: Accept-Encoding
content-type: image/svg+xml
cache-control: public, max-age=604800
content-disposition: inline; filename="citeline--sticky2x.svg"
cf-ray: 811275385d728ff8-FRA
expires: Thu, 12 Oct 2023 03:08:03 GMT

GET
H2 200 fifty-fifty.png
www.citeline.com/-/media/citeline/trialscope-intelligence-lp/ 62 KB
62 KB 641ms
638ms Image
image/webp 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.citeline.com/-/media/citeline/trialscope-intelligence-lp/fifty-fifty.png?la=en&h=529&w=545&hash=E26B235D3007771E7BCB5B6EE6247C4E
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 38aea1e89321b465530e9a96f6c2399a6f5bfab28f5352aca238b8e1f56a4ee0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
cf-cache-status: MISS
last-modified: Thu, 14 Sep 2023 21:02:23 GMT
server: cloudflare
vary: Accept-Encoding
content-type: image/webp
cache-control: public, max-age=604800
content-disposition: inline; filename="fifty-fifty.webp"
accept-ranges: bytes
cf-ray: 811275386d7d8ff8-FRA
content-length: 63106
expires: Thu, 12 Oct 2023 03:08:03 GMT

GET
H2 200 green-cta-panel.svg
www.citeline.com/-/media/citeline/trialscope-intelligence-lp/ 3 MB
2 MB 731ms
729ms Image
image/svg+xml 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.citeline.com/-/media/citeline/trialscope-intelligence-lp/green-cta-panel.svg?la=en&hash=9E00497220AF5D887858CE970E39BDA4
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 5d5be8a6757b9da916ada6ef95f4b3179f1032fb42434fb81e560173adc8f04b

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
cf-cache-status: MISS
last-modified: Tue, 19 Sep 2023 20:21:19 GMT
server: cloudflare
vary: Accept-Encoding
content-type: image/svg+xml
cache-control: public, max-age=604800
content-disposition: inline; filename="green-cta-panel.svg"
cf-ray: 811275386d7e8ff8-FRA
expires: Thu, 12 Oct 2023 03:08:03 GMT

GET
H2 200 circular-frame.svg
www.citeline.com/dist/images/ 118 KB
89 KB 644ms
641ms Image
image/svg+xml 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.citeline.com/dist/images/circular-frame.svg
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 52ed63d4ab9315a9b77810871835df045b849d61305af2bf377bba758c91c2eb

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
cf-cache-status: EXPIRED
last-modified: Tue, 29 Aug 2023 11:33:15 GMT
server: cloudflare
etag: W/"65d6fa996cdad91:0"
vary: Accept-Encoding
content-type: image/svg+xml
cache-control: public, max-age=14400
cf-ray: 811275386d7f8ff8-FRA
expires: Thu, 05 Oct 2023 07:08:03 GMT

GET
H2 200 specialist-form-hero-image.jpg
www.citeline.com/-/media/citeline/hero-images/specialst-form-hero/ 18 KB
18 KB 558ms
556ms Image
image/webp 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.citeline.com/-/media/citeline/hero-images/specialst-form-hero/specialist-form-hero-image.jpg?la=en&h=416&w=416&hash=F4E812553C79761E9A98E9FBC2B28B25
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 915fe123f1a839d2f3b7accd8a0d39e4b96700025c57b061dcb255f7f5a7f8d1

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
cf-cache-status: MISS
last-modified: Wed, 07 Jun 2023 09:55:48 GMT
server: cloudflare
vary: Accept-Encoding
content-type: image/webp
cache-control: public, max-age=604800
content-disposition: inline; filename="Specialist Form Hero Image.webp"
accept-ranges: bytes
cf-ray: 811275386d808ff8-FRA
content-length: 18686
expires: Thu, 12 Oct 2023 03:08:03 GMT

GET
H2 200 api.js Show response
www.google.com/recaptcha/ 1 KB
1 KB 143ms
49ms Script
text/javascript 2a00:1450:4001:831::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api.js?onload=handleFastTrackReCaptchaLoaded&hl=en

Requested by

Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:831::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

d383ca7f8134b3ad72f747da10b2ef2003d77d78855fb79474320f655e1dc72d

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
x-content-type-options: nosniff
content-security-policy: frame-ancestors 'self'
server: GSE
x-frame-options: SAMEORIGIN
content-type: text/javascript; charset=UTF-8
cache-control: private, max-age=300
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection: 1; mode=block
expires: Thu, 05 Oct 2023 03:08:03 GMT

GET
H/1.1 200
OK livevalidation_standalone.compressed.js Show response
img06.en25.com/i/ 13 KB
14 KB 151ms
46ms Script
application/x-javascript 184.25.216.9
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL

https://img06.en25.com/i/livevalidation_standalone.compressed.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_256_GCM

Server

184.25.216.9 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),

Reverse DNS

a184-25-216-9.deploy.static.akamaitechnologies.com

Software

Resource Hash

36ef1cf6246ce3d596a572d7b0e947a7088eefb1af6373f1a0669c9189a6728e

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

Pragma: no-cache
Strict-Transport-Security: max-age=31536000; includeSubDomains; preload
Date: Thu, 05 Oct 2023 03:08:03 GMT
X-Content-Type-Options: nosniff
Last-Modified: Mon, 17 Jul 2023 19:34:32 GMT
ETag: "94b219b6e5b8d91:0"
P3P: CP="IDC DSP COR DEVa TAIa OUR BUS PHY ONL UNI COM NAV CNT STA",
Content-Type: application/x-javascript
Cache-Control: no-store
Connection: keep-alive
Accept-Ranges: bytes
X-Robots-Tag: noindex, nofollow
Content-Length: 13723
X-XSS-Protection: 1; mode=block
Expires: Thu, 05 Oct 2023 03:08:03 GMT

GET
H2 200 linkedin-icon-36x36.png
www.citeline.com/-/media/citeline/social-icons/ 459 B
584 B 450ms
448ms Image
image/png 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.citeline.com/-/media/citeline/social-icons/linkedin-icon-36x36.png?la=en&h=36&w=36&hash=A0FA3E1EC93DA791F4C55CD5FA2C2693
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 945e1e93f8c4cb3e4528b4cfd2e25c56a1bf50f2a3b9eb93783c3b503f6ee585

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
cf-cache-status: MISS
last-modified: Wed, 07 Jun 2023 11:46:39 GMT
server: cloudflare
vary: Accept-Encoding
content-type: image/png
cache-control: public, max-age=604800
content-disposition: inline; filename="Linkedin Icon 36x36.png"
accept-ranges: bytes
cf-ray: 811275386d818ff8-FRA
content-length: 459
expires: Thu, 12 Oct 2023 03:08:03 GMT

GET
H2 200 twitter-icon-36x36.png
www.citeline.com/-/media/citeline/social-icons/ 626 B
752 B 433ms
431ms Image
image/webp 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.citeline.com/-/media/citeline/social-icons/twitter-icon-36x36.png?la=en&h=36&w=36&hash=0AEF568ED494352887700BE360E56D02
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: bd847bff8eac197d4e89bc58c8734995c4be42f5d758cae64935fd3eee4cbf8c

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
cf-cache-status: MISS
last-modified: Thu, 28 Sep 2023 11:19:50 GMT
server: cloudflare
vary: Accept-Encoding
content-type: image/webp
cache-control: public, max-age=604800
content-disposition: inline; filename="Twitter Icon 36x36.webp"
accept-ranges: bytes
cf-ray: 811275386d828ff8-FRA
content-length: 626
expires: Thu, 12 Oct 2023 03:08:03 GMT

GET
H2 200 youtube-icon-36x36.png
www.citeline.com/-/media/citeline/social-icons/ 439 B
532 B 459ms
457ms Image
image/png 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.citeline.com/-/media/citeline/social-icons/youtube-icon-36x36.png?la=en&h=36&w=36&hash=EFB52256BED0D3558F7BDFCEC7EF5BFC
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 35ea9acfe9b6cf451bf5458d145f69051176855fecc295fc57cb447297661664

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
cf-cache-status: MISS
last-modified: Wed, 07 Jun 2023 11:46:39 GMT
server: cloudflare
vary: Accept-Encoding
content-type: image/png
cache-control: public, max-age=604800
content-disposition: inline; filename="Youtube Icon 36x36.png"
accept-ranges: bytes
cf-ray: 811275386d838ff8-FRA
content-length: 439
expires: Thu, 12 Oct 2023 03:08:03 GMT

GET
H2 200 citeline_logo_negative_dual_color-1.png
www.citeline.com/-/media/images/logos/ 1 KB
1 KB 449ms
447ms Image
image/webp 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.citeline.com/-/media/images/logos/citeline_logo_negative_dual_color-1.png?la=en&h=64&w=192&hash=A61685649BBF5B3FC7E3D9F2172E8505
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 4db2a9e83e18ece8f827d7ccb2da535692472d49691b11d1288ae308048f4d73

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
cf-cache-status: MISS
last-modified: Fri, 24 Mar 2023 12:17:59 GMT
server: cloudflare
vary: Accept-Encoding
content-type: image/webp
cache-control: public, max-age=604800
content-disposition: inline; filename="Citeline_Logo_Negative_Dual_Color 1.webp"
accept-ranges: bytes
cf-ray: 811275386d848ff8-FRA
content-length: 1384
expires: Thu, 12 Oct 2023 03:08:03 GMT

GET
H2 200 app.js Show response
www.citeline.com/dist/js/ 117 KB
49 KB 148ms
147ms Script
application/javascript 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://www.citeline.com/dist/js/app.js?v=638289056110760708
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: a754114690424ca8fd854b8b9f6854ef585403df73644ffc3e4f1ae3fe91a798

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
cf-cache-status: REVALIDATED
last-modified: Tue, 29 Aug 2023 11:33:31 GMT
server: cloudflare
etag: "4539a36cdad91:0"
vary: Accept-Encoding
content-type: application/javascript
cache-control: public, max-age=14400
accept-ranges: bytes
cf-ray: 811275386d858ff8-FRA
content-length: 50167
expires: Thu, 05 Oct 2023 07:08:03 GMT

GET
H2 200 fbevents.js Show response
connect.facebook.net/en_US/ 198 KB
53 KB 127ms
41ms Script
application/x-javascript 2a03:2880:f083:9:face:b00c:0:3
FACEBOOK

General

Check archive.org

Show headers Download Go to

Full URL

https://connect.facebook.net/en_US/fbevents.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a03:2880:f083:9:face:b00c:0:3 Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),

Reverse DNS

Software

Resource Hash

805270b078cde87b61bb57c8bd44f8b58b0d128f5a8efdd4395470b45b291d65

Security Headers

Name	Value
Content-Security-Policy	default-src * data: blob: 'self';script-src .facebook.com .fbcdn.net .facebook.net .google-analytics.com .google.com 127.0.0.1: 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' ;connect-src .facebook.com facebook.com .fbcdn.net .facebook.net wss://.facebook.com: wss://.whatsapp.com: wss://.fbcdn.net attachment.fbsbx.com ws://localhost: blob: *.cdninstagram.com 'self';block-all-mixed-content;upgrade-insecure-requests;require-trusted-types-for 'script';
Strict-Transport-Security	max-age=31536000; preload; includeSubDomains
X-Content-Type-Options	nosniff
X-Frame-Options	DENY
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

content-security-policy: default-src * data: blob: 'self';script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.google.com 127.0.0.1:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net wss://*.facebook.com:* wss://*.whatsapp.com:* wss://*.fbcdn.net attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';block-all-mixed-content;upgrade-insecure-requests;require-trusted-types-for 'script';
content-encoding: gzip
x-content-type-options: nosniff
strict-transport-security: max-age=31536000; preload; includeSubDomains
date: Thu, 05 Oct 2023 03:08:03 GMT
document-policy: force-load-at-top
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=86400
content-length: 53356
x-xss-protection: 0
pragma: public
x-fb-debug: R+HqrAlgjAu2pneQdvRsFzedHOGecCGVhvJmfgMTxJcRhHTozatxiSV9giy43c/F/3RzZwGaV3QXFxmGcdieww==
cross-origin-opener-policy: same-origin-allow-popups
vary: Accept-Encoding
x-frame-options: DENY
content-type: application/x-javascript; charset=utf-8
cache-control: public, max-age=1200
permissions-policy: accelerometer=(), ambient-light-sensor=(), bluetooth=(), camera=(), gyroscope=(), hid=(), idle-detection=(), magnetometer=(), microphone=(), midi=(), payment=(), screen-wake-lock=(), serial=(), usb=()
expires: Sat, 01 Jan 2000 00:00:00 GMT

GET
H2 200 gtm.js Show response
www.googletagmanager.com/ 270 KB
87 KB 149ms
61ms Script
application/javascript 2a00:1450:4001:830::2008
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtm.js?id=GTM-K65LT6

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:830::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

ee3ff423f1ff846f3baf39e1c00803e9f61bc281d790c55b12e4aa627bb9ebe3

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains
server: Google Tag Manager
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
access-control-allow-headers: Cache-Control
content-length: 88915
x-xss-protection: 0
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires: Thu, 05 Oct 2023 03:08:03 GMT

GET
H2 200 icons.svg
www.citeline.com/dist/icons/ 11 KB
3 KB 497ms
496ms Other
image/svg+xml 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://www.citeline.com/dist/icons/icons.svg
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 71355ecd54d429bc448b6171a41d84277f06789cb0d07e2bbcb2ca0943364c3b

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
cf-cache-status: REVALIDATED
last-modified: Tue, 29 Aug 2023 11:33:04 GMT
server: cloudflare
etag: W/"eb8d24936cdad91:0"
vary: Accept-Encoding
content-type: image/svg+xml
cache-control: public, max-age=14400
cf-ray: 81127538ada18ff8-FRA
expires: Thu, 05 Oct 2023 07:08:03 GMT

GET
H2 200 particles-wave-pink-desktop.png
www.citeline.com/dist/images/ 193 KB
193 KB 453ms
453ms Image
image/png 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.citeline.com/dist/images/particles-wave-pink-desktop.png
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/dist/css/styles.css?v=638289055950845756
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 56643b659f3731b628215112686198a45112dd29d27adf24799ef192a9af34a1

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/dist/css/styles.css?v=638289055950845756
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
cf-cache-status: REVALIDATED
last-modified: Tue, 29 Aug 2023 11:33:25 GMT
server: cloudflare
etag: "409e9c9f6cdad91:0"
vary: Accept-Encoding
content-type: image/png
cache-control: public, max-age=14400
accept-ranges: bytes
cf-ray: 81127538ada28ff8-FRA
content-length: 197446
expires: Thu, 05 Oct 2023 07:08:03 GMT

GET
H2 200 hero-gradient-pink-desktop.jpg
www.citeline.com/dist/images/ 81 KB
82 KB 465ms
465ms Image
image/jpeg 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.citeline.com/dist/images/hero-gradient-pink-desktop.jpg
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/dist/css/styles.css?v=638289055950845756
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 6f0c24f47af58868b1318574b3c1a29f9ccc548f0c8040fb63f0d30fd57bca78

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/dist/css/styles.css?v=638289055950845756
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
cf-cache-status: REVALIDATED
cf-bgj: h2pri
last-modified: Tue, 29 Aug 2023 11:33:05 GMT
server: cloudflare
etag: "62fec1936cdad91:0"
vary: Accept-Encoding
content-type: image/jpeg
cache-control: public, max-age=14400
accept-ranges: bytes
cf-ray: 81127538ada38ff8-FRA
content-length: 83343
expires: Thu, 05 Oct 2023 07:08:03 GMT

GET
H2 200 play-button.svg
www.citeline.com/assets/icons/ 963 B
653 B 432ms
432ms Image
image/svg+xml 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.citeline.com/assets/icons/play-button.svg
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/dist/css/styles.css?v=638289055950845756
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 9b92ecf753a3f70908acdb2a472e475d7b13aede70528b8d3db5c97786648f00

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/dist/css/styles.css?v=638289055950845756
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
cf-cache-status: REVALIDATED
last-modified: Tue, 29 Aug 2023 11:27:22 GMT
server: cloudflare
etag: W/"c53828c76bdad91:0"
vary: Accept-Encoding
content-type: image/svg+xml
cache-control: public, max-age=14400
cf-ray: 81127538ada48ff8-FRA
expires: Thu, 05 Oct 2023 07:08:03 GMT

GET
H2 200 lexend-v17-latin-500.woff2
www.citeline.com/dist/fonts/ 12 KB
12 KB 467ms
467ms Font
application/font-woff2 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://www.citeline.com/dist/fonts/lexend-v17-latin-500.woff2
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/dist/css/styles.css?v=638289055950845756
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: fbef5c53fcddebd274e4ab57d841402de8e7618d497430fec408ca7e6af426d8

Request headers

Referer: https://www.citeline.com/dist/css/styles.css?v=638289055950845756
Origin: https://www.citeline.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
cf-cache-status: REVALIDATED
last-modified: Tue, 29 Aug 2023 11:33:04 GMT
server: cloudflare
etag: "147b11936cdad91:0"
vary: Accept-Encoding
content-type: application/font-woff2
cache-control: public, max-age=14400
accept-ranges: bytes
cf-ray: 81127538ada58ff8-FRA
content-length: 12608
expires: Thu, 05 Oct 2023 07:08:03 GMT

GET
H2 200 lexend-v17-latin-regular.woff2
www.citeline.com/dist/fonts/ 12 KB
12 KB 459ms
459ms Font
application/font-woff2 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://www.citeline.com/dist/fonts/lexend-v17-latin-regular.woff2
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/dist/css/styles.css?v=638289055950845756
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: c752cf03fc65cd47a8e5559d1a96847770a5c7c34baada82a3dc4df7733f1e7a

Request headers

Referer: https://www.citeline.com/dist/css/styles.css?v=638289055950845756
Origin: https://www.citeline.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
cf-cache-status: REVALIDATED
last-modified: Tue, 29 Aug 2023 11:33:04 GMT
server: cloudflare
etag: "99dd13936cdad91:0"
vary: Accept-Encoding
content-type: application/font-woff2
cache-control: public, max-age=14400
accept-ranges: bytes
cf-ray: 81127538ada68ff8-FRA
content-length: 12296
expires: Thu, 05 Oct 2023 07:08:03 GMT

GET
H2 200 recaptcha__en.js Show response
www.gstatic.com/recaptcha/releases/lLirU0na9roYU3wDDisGJEVT/ 464 KB
186 KB 129ms
39ms Script
text/javascript 2a00:1450:4001:828::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/lLirU0na9roYU3wDDisGJEVT/recaptcha__en.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:828::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

b1a65063717196413801187164cad067a3c8b3f1c8d7cf768de32d1230ecdf3c

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.citeline.com/
Origin: https://www.citeline.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 01:26:43 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 6080
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 189597
x-xss-protection: 0
last-modified: Mon, 02 Oct 2023 04:05:03 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Fri, 04 Oct 2024 01:26:43 GMT

GET
H2 200 35b370f5d08f87611b47.js Show response
www.citeline.com/dist/js/ 2 KB
890 B 424ms
424ms Script
application/javascript 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://www.citeline.com/dist/js/35b370f5d08f87611b47.js
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 75d2aa4fe553b4578a547258d7a5f0992131a0cd2d96628a1e73567ca3f921f0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
cf-cache-status: REVALIDATED
last-modified: Tue, 29 Aug 2023 11:33:31 GMT
server: cloudflare
etag: "4539a36cdad91:0"
vary: Accept-Encoding
content-type: application/javascript
cache-control: public, max-age=14400
accept-ranges: bytes
cf-ray: 811275398e0d8ff8-FRA
content-length: 756
expires: Thu, 05 Oct 2023 07:08:03 GMT

GET
H2 200 3288bdce60a02e60c248.js Show response
www.citeline.com/dist/js/ 15 KB
6 KB 423ms
422ms Script
application/javascript 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://www.citeline.com/dist/js/3288bdce60a02e60c248.js
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 00803178caba018dd821cfa254d01b14872b1abc2f086234a56d8e7c7007bf75

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
cf-cache-status: REVALIDATED
last-modified: Tue, 29 Aug 2023 11:33:31 GMT
server: cloudflare
etag: "4539a36cdad91:0"
vary: Accept-Encoding
content-type: application/javascript
cache-control: public, max-age=14400
accept-ranges: bytes
cf-ray: 811275399e0f8ff8-FRA
content-length: 6413
expires: Thu, 05 Oct 2023 07:08:03 GMT

GET
H2 200 c7a3a0bbe2aeea2f2440.js Show response
www.citeline.com/dist/js/ 17 KB
6 KB 401ms
400ms Script
application/javascript 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://www.citeline.com/dist/js/c7a3a0bbe2aeea2f2440.js
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 4ffd3d99bf183ca05a43499e95c5ad901c5ae0ef27f1e6e52e14d3de0b7a709e

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
cf-cache-status: REVALIDATED
last-modified: Tue, 29 Aug 2023 11:33:31 GMT
server: cloudflare
etag: "4539a36cdad91:0"
vary: Accept-Encoding
content-type: application/javascript
cache-control: public, max-age=14400
accept-ranges: bytes
cf-ray: 811275399e108ff8-FRA
content-length: 5651
expires: Thu, 05 Oct 2023 07:08:03 GMT

GET
H2 200 7fab6fc6531f9accee0b.js Show response
www.citeline.com/dist/js/ 2 KB
1 KB 434ms
434ms Script
application/javascript 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://www.citeline.com/dist/js/7fab6fc6531f9accee0b.js
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: dc42be831be8d695da75e8cef5ed608db69b08070806c956c3d3f33fd2111550

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
cf-cache-status: REVALIDATED
last-modified: Tue, 29 Aug 2023 11:33:31 GMT
server: cloudflare
etag: "21b5ba36cdad91:0"
vary: Accept-Encoding
content-type: application/javascript
cache-control: public, max-age=14400
accept-ranges: bytes
cf-ray: 811275399e118ff8-FRA
content-length: 1207
expires: Thu, 05 Oct 2023 07:08:03 GMT

GET
H2 200 b8297194bc1272395d72.js Show response
www.citeline.com/dist/js/ 78 KB
30 KB 537ms
535ms Script
application/javascript 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://www.citeline.com/dist/js/b8297194bc1272395d72.js
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 64285b7cd2a9ff5a376d711242912365b96bc8a227903d9f191e812bd335e5b8

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
cf-cache-status: MISS
last-modified: Tue, 29 Aug 2023 11:33:31 GMT
server: cloudflare
etag: "4539a36cdad91:0"
vary: Accept-Encoding
content-type: application/javascript
cache-control: public, max-age=14400
accept-ranges: bytes
cf-ray: 811275399e128ff8-FRA
content-length: 30454
expires: Thu, 05 Oct 2023 07:08:03 GMT

GET
H2 200 e93e064ec288524a382d.js Show response
www.citeline.com/dist/js/ 17 KB
7 KB 436ms
435ms Script
application/javascript 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://www.citeline.com/dist/js/e93e064ec288524a382d.js
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: b83dc6c9c1dccad6f1bd0224421ec3a2f8a96bffce62a5b2606456f11102b0b1

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
cf-cache-status: REVALIDATED
last-modified: Tue, 29 Aug 2023 11:33:31 GMT
server: cloudflare
etag: "4539a36cdad91:0"
vary: Accept-Encoding
content-type: application/javascript
cache-control: public, max-age=14400
accept-ranges: bytes
cf-ray: 811275399e138ff8-FRA
content-length: 7138
expires: Thu, 05 Oct 2023 07:08:03 GMT

GET
H2 200 f54afd81a0c458e4f428.js Show response
www.citeline.com/dist/js/ 18 KB
6 KB 438ms
437ms Script
application/javascript 2606:4700::6812:12aa
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://www.citeline.com/dist/js/f54afd81a0c458e4f428.js
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:12aa , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 4e79b528a5ed9d6a67c0259d4a65f256d79ec852f7a9cdc2ce48beff88c9debf

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
cf-cache-status: REVALIDATED
last-modified: Tue, 29 Aug 2023 11:33:31 GMT
server: cloudflare
etag: "4539a36cdad91:0"
vary: Accept-Encoding
content-type: application/javascript
cache-control: public, max-age=14400
accept-ranges: bytes
cf-ray: 811275399e148ff8-FRA
content-length: 5893
expires: Thu, 05 Oct 2023 07:08:03 GMT

GET
H2 200 699979251945956 Show response
connect.facebook.net/signals/config/ 131 KB
35 KB 107ms
106ms Script
application/x-javascript 2a03:2880:f083:9:face:b00c:0:3
FACEBOOK

General

Check archive.org

Show headers Download Go to

Full URL

https://connect.facebook.net/signals/config/699979251945956?v=2.9.132&r=stable&domain=www.citeline.com

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a03:2880:f083:9:face:b00c:0:3 Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),

Reverse DNS

Software

Resource Hash

ee191959e9a3815e6cbdecab3983a3c3c605596d45e0bcf97b55fc7caf70c9c0

Security Headers

Name	Value
Content-Security-Policy	default-src facebook.net .facebook.net fbcdn.net .fbcdn.net fbsbx.com .fbsbx.com data: blob: 'self';script-src .fbcdn.net .facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net .facebook.net fbcdn.net .fbcdn.net fbsbx.com .fbsbx.com;connect-src .fbcdn.net .facebook.net wss://*.fbcdn.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;require-trusted-types-for 'script';
Strict-Transport-Security	max-age=31536000; preload; includeSubDomains
X-Content-Type-Options	nosniff
X-Frame-Options	DENY
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

content-security-policy: default-src facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com data: blob: 'self';script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net wss://*.fbcdn.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;require-trusted-types-for 'script';
content-encoding: gzip
x-content-type-options: nosniff
strict-transport-security: max-age=31536000; preload; includeSubDomains
date: Thu, 05 Oct 2023 03:08:03 GMT
document-policy: force-load-at-top
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=86400
x-xss-protection: 0
pragma: public
x-fb-debug: WU2pNhZ4w3l1gqh8Rz7km5fA/1Y3iGT+YVeO/Cx+cg3F1FSNzZk9XWwBPKvwYEujQTOCr56SbZTOlcYSE4aLfQ==
cross-origin-opener-policy: same-origin-allow-popups
vary: Accept-Encoding
x-frame-options: DENY
content-type: application/x-javascript; charset=utf-8
origin-agent-cluster: ?0
cache-control: public, max-age=1200
permissions-policy: accelerometer=(), ambient-light-sensor=(), bluetooth=(), camera=(), gyroscope=(), hid=(), idle-detection=(), magnetometer=(), microphone=(), midi=(), payment=(), screen-wake-lock=(), serial=(), usb=()
expires: Sat, 01 Jan 2000 00:00:00 GMT

GET
H2 200 otSDKStub.js Show response
cdn.cookielaw.org/scripttemplates/ 21 KB
7 KB 133ms
49ms Script
application/javascript 2606:4700::6812:83ec
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/scripttemplates/otSDKStub.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

3d62ad0f23c60258f120e52cf68b2e1adff5c1bf5bde5ac8f8d6e5f4c4c64f34

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

x-ms-blob-type: BlockBlob
date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
content-md5: h6ThlO7ea17v6JNPXbI1zQ==
age: 21647
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-length: 6822
x-ms-lease-status: unlocked
last-modified: Wed, 04 Oct 2023 06:42:49 GMT
server: cloudflare
etag: 0x8DBC4A52094F396
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: *
x-ms-request-id: fa1a2d4e-501e-008b-7dfb-f63dee000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 8112753a8e33377b-FRA

GET
H/1.1 200
OK %7Bb2589596-4380-459d-aa2c-72a6ed1c4e94%7D_industry-picklist-js.js Show response
images.info.citeline.com/Web/Citeline/ 32 KB
5 KB 246ms
54ms Script
application/x-javascript 23.53.43.147
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL

https://images.info.citeline.com/Web/Citeline/%7Bb2589596-4380-459d-aa2c-72a6ed1c4e94%7D_industry-picklist-js.js

Requested by

Protocol

HTTP/1.1

Security

TLS 1.3, , AES_256_GCM

Server

23.53.43.147 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),

Reverse DNS

a23-53-43-147.deploy.static.akamaitechnologies.com

Software

Resource Hash

ad8bfb3f8ad388e429f526ff46e0d5a300fc097efa7206c8aabb21078ec45240

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

Pragma: no-cache
Date: Thu, 05 Oct 2023 03:08:03 GMT
Content-Encoding: gzip
X-Content-Type-Options: nosniff
Vary: Accept-Encoding
P3P: CP="IDC DSP COR DEVa TAIa OUR BUS PHY ONL UNI COM NAV CNT STA",
Content-Type: application/x-javascript
Cache-Control: no-store
Connection: keep-alive
X-Robots-Tag: noindex, nofollow
Content-Length: 4205
X-Xss-Protection: 1; mode=block
Expires: Thu, 05 Oct 2023 03:08:03 GMT

GET
H2 200 fs.js Show response
edge.fullstory.com/s/ 243 KB
67 KB 134ms
39ms Script
application/javascript 35.201.112.186
GOOGLE-CLOUD-PLAT...

General

Check archive.org

Show headers Download Go to

Full URL: https://edge.fullstory.com/s/fs.js
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 35.201.112.186 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS: 186.112.201.35.bc.googleusercontent.com
Software: UploadServer /
Resource Hash: f262e60c7b10558085a537c236ca7164d2dd5195f0d26c53c05d91d6675f1e48

Request headers

Referer: https://www.citeline.com/
Origin: https://www.citeline.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 02:38:43 GMT
content-encoding: br
age: 1760
x-guploader-uploadid: ADPycdv3XcH_w7dTsO1PePTN9v3IPk228a9ND4Q7heYkgU7CH3Xf8X0M_nh1YG8hLBDv0lajOntulwnSnZoko3yGHs_neQ
x-goog-storage-class: MULTI_REGIONAL
x-goog-metageneration: 1
x-goog-stored-content-encoding: br
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 68116
last-modified: Wed, 27 Sep 2023 19:45:59 GMT
server: UploadServer
etag: "e53e2cbcd3033b9de55a34f26383d01e"
vary: Accept-Encoding
x-goog-generation: 1695843959176043
x-goog-hash: crc32c=rWvM9A==, md5=5T4svNMDO53lWjTyY4PQHg==
access-control-allow-origin: *
access-control-expose-headers: Content-Length, Date, Server, Transfer-Encoding, X-GUploader-UploadID, X-Google-Trace
cache-control: public, max-age=3600,no-transform
x-goog-stored-content-length: 68116
accept-ranges: bytes
content-type: application/javascript
expires: Thu, 05 Oct 2023 03:38:43 GMT

GET
H2 200 /
www.facebook.com/tr/ 0
185 B 125ms
39ms Image
text/plain 2a03:2880:f176:84:face:b00c:0:25de
FACEBOOK

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.facebook.com/tr/?id=699979251945956&ev=PageView&dl=https%3A%2F%2Fwww.citeline.com%2Fen%2Ftrialscope-intelligence%3Futm_campaign%3DCL-TSCOPEDISC-2309-Global-trialscope%2520intelligence-new%26utm_source%3DEloqua%26utm_medium%3DEmail%26utm_content%3D2023-09-Trialscope-Intelligence-Email2%26utm_term%3DExpert%2520insights%2520on%2520clinical%2520trial%2520disclosure%2520compliance%26elqTrackId%3DACA582E5838277658255B36B64FB5865%26elq%3D3440d3db64a641bda4bb65901ae37600%26elqaid%3D5709%26elqat%3D1%26elqCampaignId%3D425&rl=&if=false&ts=1696475283610&sw=1600&sh=1200&v=2.9.132&r=stable&ec=0&o=30&fbp=fb.1.1696475283609.1962404572&ler=empty&it=1696475283476&coo=false&exp=a1&rqm=GET

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a03:2880:f176:84:face:b00c:0:25de Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),

Reverse DNS

Software

proxygen-bolt /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

strict-transport-security: max-age=31536000; includeSubDomains
date: Thu, 05 Oct 2023 03:08:03 GMT
server: proxygen-bolt
content-type: text/plain
access-control-allow-origin
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=86400
content-length: 0

GET
H2 200 aa761371-74f6-41ff-9514-e20165d57193.json Show response
cdn.cookielaw.org/consent/aa761371-74f6-41ff-9514-e20165d57193/ 5 KB
2 KB 148ms
67ms XHR
application/x-javascript 2606:4700::6812:83ec
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/consent/aa761371-74f6-41ff-9514-e20165d57193/aa761371-74f6-41ff-9514-e20165d57193.json

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

d2bf91607da9f8f3d4a9b5278933fe426fc411f6be67fce669bbeb99cd7d62b3

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

x-ms-blob-type: BlockBlob
date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
strict-transport-security: max-age=31536000; includeSubDomains; preload
age: 41376
content-md5: DP6smTbjxRQUSNhByg0vjQ==
content-length: 1846
x-ms-lease-status: unlocked
last-modified: Tue, 22 Aug 2023 14:38:26 GMT
server: cloudflare
etag: 0x8DBA31D7232FA2F
vary: Accept-Encoding
content-type: application/x-javascript
access-control-allow-origin: *
x-ms-request-id: de9a2872-901e-0094-0d06-d58eea000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Cache-Control,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: public, max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 8112753b58799b7c-FRA
expires: Fri, 06 Oct 2023 03:08:03 GMT

GET
H2 200 anchor Show response
www.google.com/recaptcha/api2/ Frame 89CB 58 KB
33 KB 65ms
64ms Document
text/html 2a00:1450:4001:831::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcGZr0mAAAAAEujkAfXWCr8dQJBU2ty4sQmu-e4&co=aHR0cHM6Ly93d3cuY2l0ZWxpbmUuY29tOjQ0Mw..&hl=en&v=lLirU0na9roYU3wDDisGJEVT&theme=light&size=normal&cb=6z5co1sy9x1j

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:831::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

2a8ff95de9085516fe6b3cbc7bc87599fb29bbfe4ed080b1e285ef2487b87759

Security Headers

Name	Value
Content-Security-Policy	script-src 'report-sample' 'nonce-7w6Xjo58HDtch_6lH4dhPg' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Referer: https://www.citeline.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36
accept-language: de-DE,de;q=0.9

Response headers

alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: no-cache, no-store, max-age=0, must-revalidate
content-encoding: gzip
content-security-policy: script-src 'report-sample' 'nonce-7w6Xjo58HDtch_6lH4dhPg' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type: text/html; charset=utf-8
cross-origin-embedder-policy: require-corp
cross-origin-resource-policy: cross-origin
date: Thu, 05 Oct 2023 03:08:03 GMT
expires: Mon, 01 Jan 1990 00:00:00 GMT
pragma: no-cache
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server: GSE
x-content-type-options: nosniff
x-xss-protection: 1; mode=block

GET
H2 200 web Show response
edge.fullstory.com/s/settings/15P6FM/v1/ 4 KB
1 KB 144ms
144ms XHR
application/json 35.201.112.186
GOOGLE-CLOUD-PLAT...

General

Check archive.org

Show headers Download Go to

Full URL: https://edge.fullstory.com/s/settings/15P6FM/v1/web
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 35.201.112.186 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS: 186.112.201.35.bc.googleusercontent.com
Software: UploadServer /
Resource Hash: 2fc34f0a95eb0c55d1e80c8ddc9299e8eb2460be193a86246bd048287901b0a0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
age: 0
x-guploader-uploadid: ADPycdud32wIOKEWQVrXpV2rGHN3uld5TM3yhVx3bq2wCVMug7P7pXaFO00tJJ45v0aJRZj0COQw1BFD6xJUmYgsUb5FzpmV27_z
x-goog-storage-class: MULTI_REGIONAL
x-goog-metageneration: 1
x-goog-stored-content-encoding: gzip
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 1178
last-modified: Thu, 05 Oct 2023 02:58:41 GMT
server: UploadServer
etag: "9eee5547f7bf436cf7ada5fe6da4cb40"
x-goog-generation: 1696069721029790
x-goog-hash: crc32c=ZmwLrw==, md5=nu5VR/e/Q2z3raX+baTLQA==
access-control-allow-origin: *
access-control-expose-headers: Content-Length, Date, Server, Transfer-Encoding, X-GUploader-UploadID, X-Google-Trace
cache-control: public,max-age=900,no-transform
x-goog-stored-content-length: 1178
accept-ranges: bytes
content-type: application/json
expires: Thu, 05 Oct 2023 03:23:03 GMT

GET
H3 200 styles__ltr.css
www.gstatic.com/recaptcha/releases/lLirU0na9roYU3wDDisGJEVT/ Frame 89CB 55 KB
24 KB 122ms
40ms Stylesheet
text/css 2a00:1450:4001:828::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/lLirU0na9roYU3wDDisGJEVT/styles__ltr.css

Requested by

Host: www.google.com
URL: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcGZr0mAAAAAEujkAfXWCr8dQJBU2ty4sQmu-e4&co=aHR0cHM6Ly93d3cuY2l0ZWxpbmUuY29tOjQ0Mw..&hl=en&v=lLirU0na9roYU3wDDisGJEVT&theme=light&size=normal&cb=6z5co1sy9x1j

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:828::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

7859a62e04b0acb06516eb12454de6673883ecfaeaed6c254659bca7cd59c050

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Wed, 04 Oct 2023 14:19:44 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 46099
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 24606
x-xss-protection: 0
last-modified: Mon, 02 Oct 2023 04:05:03 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/css
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Thu, 03 Oct 2024 14:19:44 GMT

GET
H3 200 recaptcha__en.js Show response
www.gstatic.com/recaptcha/releases/lLirU0na9roYU3wDDisGJEVT/ Frame 89CB 464 KB
185 KB 120ms
40ms Script
text/javascript 2a00:1450:4001:828::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/lLirU0na9roYU3wDDisGJEVT/recaptcha__en.js

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:828::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

b1a65063717196413801187164cad067a3c8b3f1c8d7cf768de32d1230ecdf3c

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 01:26:43 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 6080
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 189597
x-xss-protection: 0
last-modified: Mon, 02 Oct 2023 04:05:03 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Fri, 04 Oct 2024 01:26:43 GMT

GET
H2 200 location Show response
geolocation.onetrust.com/cookieconsentpub/v1/geo/ 59 B
295 B 140ms
57ms XHR
application/json 2606:4700:4400::ac40:9b77
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://geolocation.onetrust.com/cookieconsentpub/v1/geo/location

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700:4400::ac40:9b77 , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

2157361193375a79ade3559e960f982daa8d599cf7f4a92d36e3eef257738f16

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload

Request headers

accept: application/json
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:03 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-encoding: gzip
server: cloudflare
vary: Accept-Encoding
access-control-allow-methods: GET, OPTIONS
content-type: application/json
access-control-allow-origin: *
cf-ray: 8112753c698abb7a-FRA
access-control-allow-headers: Content-Type

POST
H2 202 page Show response
rs.fullstory.com/rec/ 78 B
286 B 280ms
158ms XHR
text/plain 35.186.194.58
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://rs.fullstory.com/rec/page

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

35.186.194.58 Kansas City, United States, ASN15169 (GOOGLE, US),

Reverse DNS

58.194.186.35.bc.googleusercontent.com

Software

Resource Hash

bb2455a21c4f24dda634eca977c9715be0692877af354d3a8bd51c7c91af01be

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36
Content-Type: text/plain

Response headers

date: Thu, 05 Oct 2023 03:08:04 GMT
via: 1.1 google
x-content-type-options: nosniff
content-type: text/plain; charset=utf-8
access-control-allow-origin: https://www.citeline.com
access-control-allow-credentials: true
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 78

GET
H2 200 otBannerSdk.js Show response
cdn.cookielaw.org/scripttemplates/202307.1.0/ 405 KB
98 KB 51ms
51ms Script
application/javascript 2606:4700::6812:83ec
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/scripttemplates/202307.1.0/otBannerSdk.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

71d07479f4b2b809e5769a352f4f55b84690289026ace7ed5395230002551a11

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

x-ms-blob-type: BlockBlob
date: Thu, 05 Oct 2023 03:08:03 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
content-md5: orDm7smwsr/pjTi/DOTSGQ==
age: 19326
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-length: 99815
x-ms-lease-status: unlocked
last-modified: Wed, 02 Aug 2023 03:24:04 GMT
server: cloudflare
etag: 0x8DB9307EC3B2CDE
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: *
x-ms-request-id: a7ed9111-701e-0095-7b03-c5b9d5000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 8112753ccfd3377b-FRA

GET
H2 200 en.json Show response
cdn.cookielaw.org/consent/aa761371-74f6-41ff-9514-e20165d57193/0ca7750c-bada-4353-b923-16143cf47047/ 51 KB
12 KB 63ms
63ms Fetch
application/x-javascript 2606:4700::6812:83ec
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/consent/aa761371-74f6-41ff-9514-e20165d57193/0ca7750c-bada-4353-b923-16143cf47047/en.json

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

09ccf5d8f3d10ff28667e345891cbeb64e861d6771b514cfe7e0101d6a2f00c8

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

x-ms-blob-type: BlockBlob
date: Thu, 05 Oct 2023 03:08:04 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
strict-transport-security: max-age=31536000; includeSubDomains; preload
age: 40938
content-md5: FXaI9/DkEgte9KJTl2aCzQ==
content-length: 12400
x-ms-lease-status: unlocked
last-modified: Tue, 22 Aug 2023 14:38:43 GMT
server: cloudflare
etag: 0x8DBA31D7BDE60F0
vary: Accept-Encoding
content-type: application/x-javascript
access-control-allow-origin: *
x-ms-request-id: 1c675770-b01e-003a-21fb-e123fb000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Cache-Control,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: public, max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 8112753d69909b7c-FRA
expires: Fri, 06 Oct 2023 03:08:04 GMT

GET
DATA 200
OK truncated
/ Frame 89CB 14 KB
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 0964d141519db34adc6aa127a33dbc6761cda1e56b584ea402082d99c44afb9e

Request headers

accept-language: de-DE,de;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

Content-Type: image/png

GET
DATA 200
OK truncated
/ Frame 89CB 2 KB
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 43ef4025567f7a15859b5252b6ccc1efe2ff8c7331b1aefbea7ce88eb5084d27

Request headers

accept-language: de-DE,de;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

Content-Type: image/png

GET
H3 200 logo_48.png
www.gstatic.com/recaptcha/api2/ Frame 89CB 2 KB
2 KB 42ms
41ms Image
image/png 2a00:1450:4001:828::2003
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.gstatic.com/recaptcha/api2/logo_48.png

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/lLirU0na9roYU3wDDisGJEVT/styles__ltr.css

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:828::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

1b9efb22c938500971aac2b2130a475fa23684dd69e43103894968df83145b8a

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.gstatic.com/recaptcha/releases/lLirU0na9roYU3wDDisGJEVT/styles__ltr.css
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Sat, 30 Sep 2023 06:02:48 GMT
x-content-type-options: nosniff
age: 421516
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 2228
x-xss-protection: 0
last-modified: Tue, 03 Mar 2020 20:15:00 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: image/png
cache-control: public, max-age=604800
accept-ranges: bytes
expires: Sat, 07 Oct 2023 06:02:48 GMT

GET
H2 200 KFOmCnqEu92Fr1Mu4mxK.woff2
fonts.gstatic.com/s/roboto/v18/ Frame 89CB 15 KB
16 KB 129ms
39ms Font
font/woff2 2a00:1450:4001:82b::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/roboto/v18/KFOmCnqEu92Fr1Mu4mxK.woff2

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:82b::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

3e253b66056519aa065b00a453bac37ac5ed8f3e6fe7b542e93a9dcdcc11d0bc

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.google.com/
Origin: https://www.google.com
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Sat, 30 Sep 2023 02:58:03 GMT
x-content-type-options: nosniff
age: 432601
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 15344
x-xss-protection: 0
last-modified: Mon, 16 Oct 2017 17:32:55 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Sun, 29 Sep 2024 02:58:03 GMT

GET
H3 200 webworker.js
www.google.com/recaptcha/api2/ Frame 89CB 102 B
135 B 52ms
52ms Other
text/javascript 2a00:1450:4001:831::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/webworker.js?hl=en&v=lLirU0na9roYU3wDDisGJEVT

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:831::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

5063a68a88966cff9baa3bf09bf0352e9c05164c66e9b4ef2c4d5453dc9e1ca7

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcGZr0mAAAAAEujkAfXWCr8dQJBU2ty4sQmu-e4&co=aHR0cHM6Ly93d3cuY2l0ZWxpbmUuY29tOjQ0Mw..&hl=en&v=lLirU0na9roYU3wDDisGJEVT&theme=light&size=normal&cb=6z5co1sy9x1j
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:04 GMT
content-encoding: gzip
x-content-type-options: nosniff
content-security-policy: frame-ancestors 'self'
server: GSE
cross-origin-embedder-policy: require-corp
x-frame-options: SAMEORIGIN
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript; charset=UTF-8
cache-control: private, max-age=300
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection: 1; mode=block
expires: Thu, 05 Oct 2023 03:08:04 GMT

GET
H2 200 insight.min.js Show response
snap.licdn.com/li.lms-analytics/ 12 KB
4 KB 149ms
39ms Script
application/x-javascript 2a02:26f0:3500:16::215:149b
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL

https://snap.licdn.com/li.lms-analytics/insight.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:3500:16::215:149b Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),

Reverse DNS

Software

Resource Hash

28a26321734fb5f8c8fe42b5503f162fdf1469bf97e2d9c503a83cc2b3c534cd

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:04 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Tue, 05 Sep 2023 13:41:52 GMT
x-cdn: AKAM
x-amz-server-side-encryption: AES256
vary: Accept-Encoding
content-type: application/x-javascript;charset=utf-8
cache-control: max-age=29288
accept-ranges: bytes
content-length: 3822

GET
H2 200 otFloatingRounded.json Show response
cdn.cookielaw.org/scripttemplates/202307.1.0/assets/ 10 KB
3 KB 54ms
53ms Fetch
application/json 2606:4700::6812:83ec
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/scripttemplates/202307.1.0/assets/otFloatingRounded.json

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

ef072b9ae1b3c29f94781c86bcdfdb71c1e06bbc7a2f05bc65dcfa2eefdde02c

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

x-ms-blob-type: BlockBlob
date: Thu, 05 Oct 2023 03:08:04 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
content-md5: HTxP8Spn/BPGBkzqWauQ4Q==
age: 40938
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-length: 2644
x-ms-lease-status: unlocked
last-modified: Wed, 02 Aug 2023 03:23:58 GMT
server: cloudflare
etag: 0x8DB9307E8AD5C8E
vary: Accept-Encoding
content-type: application/json
access-control-allow-origin: *
x-ms-request-id: 2f1271e4-b01e-0066-242d-c56abc000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 8112753e4a029b7c-FRA

GET
H2 200 otPcPanel.json Show response
cdn.cookielaw.org/scripttemplates/202307.1.0/assets/v2/ 63 KB
13 KB 56ms
56ms Fetch
application/json 2606:4700::6812:83ec
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/scripttemplates/202307.1.0/assets/v2/otPcPanel.json

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

00b7928237d68d4ee4ee4d9c48e47ca0295e1d93ad19da367f813595efc7c539

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

x-ms-blob-type: BlockBlob
date: Thu, 05 Oct 2023 03:08:04 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
content-md5: i1GPeZv2eEVMAO6Y1rzktA==
age: 40938
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-length: 12707
x-ms-lease-status: unlocked
last-modified: Wed, 02 Aug 2023 03:24:00 GMT
server: cloudflare
etag: 0x8DB9307EA219D0E
vary: Accept-Encoding
content-type: application/json
access-control-allow-origin: *
x-ms-request-id: 108147d7-101e-0042-282d-c5f3f2000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 8112753e4a039b7c-FRA

GET
H2 200 otCookieSettingsButton.json Show response
cdn.cookielaw.org/scripttemplates/202307.1.0/assets/ 5 KB
2 KB 55ms
54ms Fetch
application/json 2606:4700::6812:83ec
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/scripttemplates/202307.1.0/assets/otCookieSettingsButton.json

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

509f2e49500fbaeb5d7e1959071f2922b693d0135080e2871e124ec8bdd08bb2

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

x-ms-blob-type: BlockBlob
date: Thu, 05 Oct 2023 03:08:04 GMT
content-encoding: gzip
x-content-type-options: nosniff
cf-cache-status: HIT
content-md5: J/OXP0fdvy1F2I+bffRnrw==
age: 41375
strict-transport-security: max-age=31536000; includeSubDomains; preload
content-length: 1766
x-ms-lease-status: unlocked
last-modified: Wed, 02 Aug 2023 03:23:59 GMT
server: cloudflare
etag: 0x8DB9307E9C4BDC1
vary: Accept-Encoding
content-type: application/json
access-control-allow-origin: *
x-ms-request-id: 77f1f735-c01e-00ae-3d2e-c5fb8b000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 8112753e4a049b7c-FRA

GET
H2 200 otCommonStyles.css Show response
cdn.cookielaw.org/scripttemplates/202307.1.0/assets/ 21 KB
4 KB 54ms
54ms Fetch
text/css 2606:4700::6812:83ec
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/scripttemplates/202307.1.0/assets/otCommonStyles.css

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

9ed6388d56fc9f2044791e0559ab4a283381791e359dc2981449955e702de56d

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

x-ms-blob-type: BlockBlob
date: Thu, 05 Oct 2023 03:08:04 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
content-encoding: gzip
content-md5: /b68gAlvQhCuyX9fCPcDyg==
age: 41375
x-ms-lease-status: unlocked
last-modified: Wed, 02 Aug 2023 03:24:08 GMT
server: cloudflare
vary: Accept-Encoding
content-type: text/css
access-control-allow-origin: *
x-ms-request-id: 58a52f52-c01e-0026-5a2e-c54352000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
cf-ray: 8112753e4a069b7c-FRA

GET
H2 200 ot_close.svg
cdn.cookielaw.org/logos/static/ 651 B
623 B 51ms
50ms Image
image/svg+xml 2606:4700::6812:83ec
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://cdn.cookielaw.org/logos/static/ot_close.svg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

901bb0e03b8c3c0a1cf4c487a177417328bb7d8c94106ecefceedd7d7f6c4ddc

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

x-ms-blob-type: BlockBlob
date: Thu, 05 Oct 2023 03:08:04 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
content-encoding: gzip
content-md5: pcXWFGpuVeSg/jVnYCseRg==
age: 30182
x-ms-lease-status: unlocked
last-modified: Wed, 04 Oct 2023 06:42:52 GMT
server: cloudflare
vary: Accept-Encoding
content-type: image/svg+xml
access-control-allow-origin: *
x-ms-request-id: 8307c7ae-f01e-0092-0b90-f6bd55000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
cf-ray: 8112753eb962377b-FRA

GET
H2 200 ot_guard_logo.svg Show response
cdn.cookielaw.org/logos/static/ 497 B
510 B 52ms
51ms Fetch
image/svg+xml 2606:4700::6812:83ec
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL

https://cdn.cookielaw.org/logos/static/ot_guard_logo.svg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

691dcdb24853a0f5ce4e6597e5713dea66799b57ffe2c2a10f28f98e0b569b19

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

x-ms-blob-type: BlockBlob
date: Thu, 05 Oct 2023 03:08:04 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
content-encoding: gzip
content-md5: tXyZydHjxQshFMbbBT1/8A==
age: 41375
x-ms-lease-status: unlocked
last-modified: Wed, 04 Oct 2023 06:42:52 GMT
server: cloudflare
vary: Accept-Encoding
content-type: image/svg+xml
access-control-allow-origin: *
x-ms-request-id: 949fa820-701e-0025-4bce-f690ff000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
cf-ray: 8112753eca529b7c-FRA

GET
H2 200 ot_company_logo.png
cdn.cookielaw.org/logos/static/ 4 KB
4 KB 50ms
49ms Image
image/png 2606:4700::6812:83ec
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://cdn.cookielaw.org/logos/static/ot_company_logo.png

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

a335fc1da4a5ffc1fcacfa3eab57506faa41f026954496becb59cf5fbcd99d0e

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

x-ms-blob-type: BlockBlob
date: Thu, 05 Oct 2023 03:08:04 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
content-md5: E8+sk/ECzKgTUVtDLikiIA==
age: 50611
content-length: 4036
x-ms-lease-status: unlocked
last-modified: Tue, 03 Oct 2023 06:34:47 GMT
server: cloudflare
etag: 0x8DBC3DAD6C64FC6
vary: Accept-Encoding
content-type: image/png
access-control-allow-origin: *
x-ms-request-id: 10911f95-401e-0001-4268-f6665f000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
accept-ranges: bytes
cf-ray: 8112753ee996377b-FRA

GET
H2 200 powered_by_logo.svg
cdn.cookielaw.org/logos/static/ 5 KB
2 KB 50ms
50ms Image
image/svg+xml 2606:4700::6812:83ec
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://cdn.cookielaw.org/logos/static/powered_by_logo.svg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),

Reverse DNS

Software

cloudflare /

Resource Hash

5fa00d047acd959697b9d7772c31dcd37bec33c70c6fbf80ab8316205d1d286d

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains; preload
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

x-ms-blob-type: BlockBlob
date: Thu, 05 Oct 2023 03:08:04 GMT
strict-transport-security: max-age=31536000; includeSubDomains; preload
x-content-type-options: nosniff
cf-cache-status: HIT
content-encoding: gzip
content-md5: Y+c301RBZNK39PvKQWrIBw==
age: 24354
x-ms-lease-status: unlocked
last-modified: Wed, 04 Oct 2023 06:42:53 GMT
server: cloudflare
vary: Accept-Encoding
content-type: image/svg+xml
access-control-allow-origin: *
x-ms-request-id: 85619407-b01e-0093-80ed-f6e289000000
access-control-expose-headers: x-ms-request-id,Server,x-ms-version,Content-Type,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control: max-age=86400
x-ms-version: 2009-09-19
cf-ray: 8112753ee998377b-FRA

GET
H3 200 bframe Show response
www.google.com/recaptcha/api2/ Frame 8975 7 KB
1 KB 54ms
53ms Document
text/html 2a00:1450:4001:831::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/bframe?hl=en&v=lLirU0na9roYU3wDDisGJEVT&k=6LcGZr0mAAAAAEujkAfXWCr8dQJBU2ty4sQmu-e4

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:831::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

e74c878c54cf3c6406d4926c72dcde34c7bbc3f22498a810bf6060a5546d8501

Security Headers

Name	Value
Content-Security-Policy	script-src 'report-sample' 'nonce-DfkTLuT1Hbt2jn4Q2IDL4Q' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Referer: https://www.citeline.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36
accept-language: de-DE,de;q=0.9

Response headers

alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: no-cache, no-store, max-age=0, must-revalidate
content-encoding: gzip
content-security-policy: script-src 'report-sample' 'nonce-DfkTLuT1Hbt2jn4Q2IDL4Q' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type: text/html; charset=utf-8
cross-origin-embedder-policy: require-corp
cross-origin-resource-policy: cross-origin
date: Thu, 05 Oct 2023 03:08:04 GMT
expires: Mon, 01 Jan 1990 00:00:00 GMT
pragma: no-cache
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server: GSE
x-content-type-options: nosniff
x-xss-protection: 1; mode=block

GET
H2 200 insight.old.min.js Show response
snap.licdn.com/li.lms-analytics/ 13 KB
5 KB 39ms
39ms Script
application/x-javascript 2a02:26f0:3500:16::215:149b
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL

https://snap.licdn.com/li.lms-analytics/insight.old.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a02:26f0:3500:16::215:149b Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),

Reverse DNS

Software

Resource Hash

fa53fcd8da139d256c0ca83b69cb37473ca627b6052368ed3327c80d9fb61e25

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:04 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Mon, 28 Aug 2023 12:14:15 GMT
x-cdn: AKAM
x-amz-server-side-encryption: AES256
vary: Accept-Encoding
content-type: application/x-javascript;charset=utf-8
cache-control: max-age=53033
accept-ranges: bytes
content-length: 4862

GET
H3 200 styles__ltr.css
www.gstatic.com/recaptcha/releases/lLirU0na9roYU3wDDisGJEVT/ Frame 8975 55 KB
24 KB 46ms
45ms Stylesheet
text/css 2a00:1450:4001:828::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/lLirU0na9roYU3wDDisGJEVT/styles__ltr.css

Requested by

Host: www.google.com
URL: https://www.google.com/recaptcha/api2/bframe?hl=en&v=lLirU0na9roYU3wDDisGJEVT&k=6LcGZr0mAAAAAEujkAfXWCr8dQJBU2ty4sQmu-e4

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:828::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

7859a62e04b0acb06516eb12454de6673883ecfaeaed6c254659bca7cd59c050

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Wed, 04 Oct 2023 14:19:44 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 46100
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 24606
x-xss-protection: 0
last-modified: Mon, 02 Oct 2023 04:05:03 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/css
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Thu, 03 Oct 2024 14:19:44 GMT

GET
H3 200 recaptcha__en.js Show response
www.gstatic.com/recaptcha/releases/lLirU0na9roYU3wDDisGJEVT/ Frame 8975 464 KB
185 KB 49ms
48ms Script
text/javascript 2a00:1450:4001:828::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/lLirU0na9roYU3wDDisGJEVT/recaptcha__en.js

Requested by

Host: www.google.com
URL: https://www.google.com/recaptcha/api2/bframe?hl=en&v=lLirU0na9roYU3wDDisGJEVT&k=6LcGZr0mAAAAAEujkAfXWCr8dQJBU2ty4sQmu-e4

Protocol

Security

QUIC, , AES_128_GCM

Server

2a00:1450:4001:828::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

b1a65063717196413801187164cad067a3c8b3f1c8d7cf768de32d1230ecdf3c

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 01:26:43 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 6081
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 189597
x-xss-protection: 0
last-modified: Mon, 02 Oct 2023 04:05:03 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Fri, 04 Oct 2024 01:26:43 GMT

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
365 B 201ms
49ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: GPg-hzCYE5EmJAf1Z1TDeX988sNJNPlTYOeAr2DZQvG9MrKa2P8rgA==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
367 B 196ms
45ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: HdMThlX1TkPtR8o3Av1-PiZBUbcyhiPqWvEpyHOoiVDrXGilXPMgzw==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
366 B 195ms
46ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: ys-KUGypQk6NVghl6uO6FC-97IP0RQqk0fAuppYl0qGqMHXvcSOZpA==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
365 B 195ms
46ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: hkz4P7FcECD90G9yfalqo-5WPkMNuGztn_rZt8B5CkKNXcMxPK1eUQ==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
365 B 195ms
47ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: qB6QhwOUzkD2u4ExqEK5iE_q9mQFVo4UOcY6Z2unKpraqOsWRNaYfQ==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 322ms
176ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: ij7NkGQEzM4oDzmU3NdMlNUnin0JfGhImeOqdTM4s2yOg_vsomLQgA==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 317ms
177ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: 6gXkJC2KwTqX9Ax_Tp0YzGfAtVBx03xrBO66zTH6qSTH-zZzfQoY3A==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 317ms
178ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: zeVkjZ0TZ79zoQ6ueXYqM-HwPFOYvJDo-WiFTAbmO6OSkCNAfPSfUQ==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 314ms
176ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: Uk1QPMyXCFCBZNyAGqZ3gOlBLQyzu80sGEevcPAYLJh3KT2M-biJuA==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 282ms
147ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: DwHOMvDpoU6LccYmbaXCZk8TvDw_LL-LhMIMYi3DSDW48T3Ri_gSIA==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 286ms
154ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: 3xBaOR-v4EnQutvRkraN5wx9yJ_d9sxhJ5Qg8Tz8_9UZ1D7exSJFMg==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 280ms
149ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: Gx931KO4OJbYEAjkxuh9dITU-nJv0ti24NMC4Sp97JyL8LcbGZjwtQ==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
354 B 305ms
175ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: A2F5sCBe4iUmDG1uoBDMRUSizgv1otr4nSm1GQrR5-q3Y0ydUl4t2g==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 304ms
174ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: 7TCzs8cs8lnISMBJCkSUIb6mGqjOtiB1RVUUah-MbEvqHFE4Z_rbFA==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 275ms
148ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: 5VO1k_H8QTxSthBb5KL5E03QrflUaWtN7eTKya8wXhLYGEjO8wTg0w==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 300ms
174ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: Us14y2jaOtug1RLKMPxCa8ykDG8GXBtMFSKJGDDNKskc1HLc778ELg==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 276ms
151ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: F_ciDV0umHCRzRRNmAFG0Nal0ibTanZckBBQEWOYh22xEUK0E6TLCw==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 272ms
148ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: tnA8GefOMi86M9pkQ0gBzgw_RsHwUDKItDC-u42CG6P_hAfG36-jHA==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 272ms
149ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: tJ1k7n1ndnAcDWjBCJGVfqFO78kAoLYLRruOvHlM4IAxzlBDIkLxoA==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 295ms
173ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: qxNwFTVcJVRdhQhYjPn-SfTxna5mOjdF-xSbepZyHiwni-T_lqYTBw==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 273ms
153ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: nPPxxypT8T11SMzDYVZVnz72nNmuk-icN2pP9E1Zkhwko2EF1SDkow==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 265ms
146ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: NCgq3_b8j4-NNXlIsDHtOGlgCXN4CUVyJZajnQ6sZmk9WgdaI201jw==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 267ms
150ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: xWX1XbO9Xf4deVHQ9agd1EzNbs3sukk4vGUwP-3iCytGVoo-b-I0mQ==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 265ms
148ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: bzbgvJAkRKTQjRTpqUjCa_qnya329zLCQkMZa2usPDZ3bi0lh8DWmA==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
355 B 264ms
150ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: p1UIlzX1BOaScqC61AZo0_cutxn-TC9tri6AuFuklDFMnPngEkl2-A==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 265ms
152ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: kWFoY0aRy8vwU6NTKzZ-C8PLjs8aQMnKh80Ooi_wkc5bmRQGOEAY5w==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 258ms
147ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: _0vo1TvwTxctn_OsGBThvjWG61pyUsLn6rYelwXBOesjQjqNPQU-Lg==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
355 B 260ms
152ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: 3j0tQSSsB49raxVo8GszCYOF5Ifq-eUeoAsHeshpJFwNYmNAxhrVZg==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 277ms
175ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: XgWtvyAFdKHCLEBNw2xeqaTyW9HxfsO1AaqRcXyFEb8N8QPysJDDpQ==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
355 B 275ms
174ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: FQ6nxtiiKEMghgaHB7VFQeUOnottB8OfS4IppxqA4L4q7Ccp_RsuhQ==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 274ms
176ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: lWIuOTLLPbILo5z3_Gn3vG9Ezdx36T0zzaiT-U23D3tEpnk_OvX_yQ==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
355 B 274ms
177ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: DlePwAEClUbahACPHtcDDssE4KIkq8vf_0jZo8Gtil97nYcwfbFPoA==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 244ms
147ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: x9nF5Z_qM8fdzrt7xhKZxORwFStJIy5lwpcLMLKsezjshzNwVMW-VA==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 240ms
146ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: 8N-wtm1Op9MMqobt9A5kTP4yk44GlGsvsOpTVwFpyGcBnifL4Vxrwg==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
355 B 240ms
146ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: 0092G4uxXSx8j5wFHib8r9nefUg6h3T73igSNvpi-CJHJLpNieKhYg==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 243ms
150ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: F8fMT8QPYEUbJzaVHxqAiPR3FLL-edwkzgRn_1u_bjGKqSP7JygKzw==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 244ms
152ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: nZF2s97DH3z-ONIWPIj_k1eOfYqGnBtvK1PASigKtEZ_Q0kCyXQ92A==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 242ms
151ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: RfVcMw37m6wlowAmB5HGh0Y7pzD08sbuSXHrXBXD2jqw1jQotep0jw==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 262ms
172ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: YgOS1cJVuBqDuxxg-0PkcpfTpeMehRPPLOm9SnSba--dQAD89pYdLQ==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
355 B 180ms
91ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: Nsc-fWn1x-u6NZMsLjhCgt0A5x97Z-fNP8riGZfgTCCicI-noLl0Bw==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 227ms
140ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: YcwSwK1hn0R9JlsDGIh3XoxFybPSRRXY8xyhs4KQhULxiKLs-5eIjQ==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 231ms
145ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: OcSvALQgEMqaK7OqYQR8qIcbqnkylZ10_9S3OXayEuMWz4lITLYcxA==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 237ms
151ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: aSwfIYSH6vzzQkSiPwEo1oJCV9My9OMEbiPEWLXsy3Sfu8C_5QxwnQ==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
358 B 230ms
145ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: jMv9Xy1kYKyDxmRqzLPhkheZPb4D5PyzUESSw8z-oHTMDbChONicKg==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 228ms
144ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: NIsGFX2Uu62GlE08RgP_rToRRUQX-CSYc64_PKopVfzIbOUfZqOdhQ==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
355 B 221ms
137ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: 5a2RE3scr6SDLsEV3KtTadcpHWZ13bDED5cBcMP2P9ABjFYaPo97mg==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 227ms
144ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: dUkZLsZ9TvhW3q1LQ_KDo2NKXGA9X1KCc_5HkPcnZlNr0eYa5jTuhw==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 221ms
139ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: jpmXxqaHDdLbbmKSFOG86j3RnVOxkvw22D87BOw_NvRhGbwBfLipKg==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 223ms
141ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: 4P3cEdDHnPkKC9QDFxX7zH1OfmpzzhHivWwa0AZn9FRh4BEV8ngrGw==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
355 B 215ms
134ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: C2rQOrb1yCmhVD0w2zPUNy7gB7k-KlQr1fYW3oJFmQ1N7c1cYdDD0A==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 222ms
142ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: d_jW9If9o4IV9qqumFMjGkuAkYkGPNy2tLILtGICMekx-S8fQS55Bw==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 221ms
142ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: tMDdiIsabO57dlg4vbnDN-6pz-NTlWZKPGMug9vIfYtDs3UKwfREiw==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
355 B 215ms
137ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: 69U2-UAHkcN_ESCkhgnhcbqxzBtkH8yJKqkde1t4M6hsg2B3sVUjYg==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
355 B 169ms
92ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: 72L10D9ahZBt5BhlhOxe7pOz0h2uTCpO6f6vjj-jT8c6VA-oV0ZdnA==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 168ms
92ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: wUj8WmGszG44_adBFtgzxCWME8PzbkojsMifILmYJPS-PxoX_PcFuQ==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 165ms
90ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: yx_ZEDRWKdmTklFGRDMvoOqVu_q2unZfee3JJTGQMtjULbM7_6kl5g==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 215ms
141ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: 0zzLTSl7U9VL7XPd4gXcpbMbbH-1Ajn0d4vrNY9RLHd756ntvL_Jew==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
355 B 213ms
140ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: 7ZrDtJ-C6eITII4upDGds__I5Od5GtW3j_cWy1fYL8sW6l8gv9Jmsg==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 209ms
136ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: JnpyYxHOMQ7fYzqn8s4tDOqNRI6cwx9kycu6VUfR_VSgLLQ9s9e2sQ==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 215ms
144ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: sDqh39_2msbnsSxrD43-S_0LR3w8QOcM3QTMhzNnIohCDDIksYR7EQ==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 213ms
142ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: PUwPZjfRSaS5OsTmosl_X0FGdjnHDyYTKKDJf8Arzrpx7v9GJ5BWDQ==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 214ms
143ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: EQK88M0N8Q9favXSjB1nsHnOQtx3MdM-6Z_ydQFm5EApB6cnpmHK7g==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 212ms
143ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: W_3NYOULzIVynU8o7TDB35qV21Iu1nDylNlWmRYq-nAh9ELEOY8L0g==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
354 B 208ms
139ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: bOkw3R8g3aK3342mhoo90jkmhmgrC_oiKnZ39N7v8tM23rthLt6tfA==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
355 B 211ms
143ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: Sen0Q74UYYe1Yra461pPphH2FE_DydxxMKdrZiSY6hY8qtoM7D6Ymg==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 202ms
135ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: TJbhjfsRUir_J0z4aa6TDofO-8K0-WdFGGgvYkmduuJZ3awFrvJBPA==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 157ms
91ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: QmYX9KNHcv7Q-y1DPk9TGTXlzdMWQ-l13BSyaI97u64oPik55yvohw==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 153ms
88ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: oAEb3jtK5hl91iEDYfII581ZPX7eHAkGEMvob8_BBjqYN-us5ZVAYw==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
366 B 111ms
47ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: r4JHDt7zULFRu-mFSAIj_piH7f77G6YMTz5IGwwDqW-AunwKh6Hkeg==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 201ms
138ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: x75IMbnM2IVGBhreM8kEMVs0pWQMX3B4qCLSGcFvBTm7R6cQcuokiA==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 197ms
135ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: 4y4bogzd9M0GNWEGCQYKpWfG6Kxv9wdaQVpknahDBZ2-1r8SHl8NeQ==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 151ms
90ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: myuWqJCqioL29FCeWE-SIooV-oe8ZWWcGdgVZMlWj5gf3nKM6gEdmw==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 148ms
88ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: hHqp718UFYCKkf1N0tPgHPMp6-3eoSBkxXA8PkhNuWG_crE3TB199w==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 146ms
87ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: KB6WQd0EJy4ryemgzehWMZALFwWq_H-xRP3xUsAkSx1D5IHrqYFnCg==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 143ms
85ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: UNCLGUy3LHgNae2E-RtcpOt-oWzcz46TXmGGv8-fPUtHpmYYVsdwkw==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 145ms
88ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: mgVgTUYdcPZNaukL5Iq4EQDMHz_UiSC0_Ih9kyvrzagheFmenFvOag==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
355 B 141ms
86ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: UN_QDE2x-nbDS9I5NOm5rT1oro72NVRPq793e34_tQE6A7yQBhR3bg==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
356 B 141ms
87ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: tQ-5p5kGpk5pA_cwIdl_KAy6ej9bEPVMXuLZaewz7GlaK5WLeyZl6Q==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
357 B 130ms
86ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: QpHu_WGhQWpbnVqwmA50cSrepAg2mIXfCvINQq4YumCXVAMBqS9IRA==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
365 B 88ms
49ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: JNblDzmOszb7OV5zAa5eED13qOgQ0phVY-WEB0pSjTqrp-cgvexC5A==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
366 B 67ms
48ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: 64ciKgNoA4iQ-y_vEAHFIJvrwZwKF85oZNjAJgSC7mNIwOdxuvNfMQ==

GET
H2

200

collect
px4.ads.linkedin.com/
Redirect Chain

https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=4341164&time=1696475284671&url=https%3A%2F%2Fwww.citeline.com%2Fen%2Ftrialscope-intelligence%3Futm_campaign%3DCL-TSCOPEDISC-2309-Global-trialscope...
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=4341164&time=1696475284671&url=https%3A%2F%2Fwww.citeline.com%2Fen%2Ftrialscope-intelligence%3Futm_campaign%3DCL-TSCOPEDISC-2309-Global-trialscope...
https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D4341164%26time%3D1696475284671%26url%3Dhttps%253A%252F%252Fwww.citeline.com%252Fe...
https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=4341164&time=1696475284671&url=https%3A%2F%2Fwww.citeline.com%2Fen%2Ftrialscope-intelligence%3Futm_campaign%3DCL-TSCOPEDISC-2309-Global-trialscope...
https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=4341164&time=1696475284671&url=https%3A%2F%2Fwww.citeline.com%2Fen%2Ftrialscope-intelligence%3Futm_campaign%3DCL-TSCOPEDISC-2309-Global-trialscop...

0
265 B

291ms
186ms

Image
application/javascript

13.107.42.14
MICROSOFT-CORP-MS...

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=4341164&time=1696475284671&url=https%3A%2F%2Fwww.citeline.com%2Fen%2Ftrialscope-intelligence%3Futm_campaign%3DCL-TSCOPEDISC-2309-Global-trialscope%2520intelligence-new%26utm_source%3DEloqua%26utm_medium%3DEmail%26utm_content%3D2023-09-Trialscope-Intelligence-Email2%26utm_term%3DExpert%2520insights%2520on%2520clinical%2520trial%2520disclosure%2520compliance%26elqTrackId%3DACA582E5838277658255B36B64FB5865%26elq%3D3440d3db64a641bda4bb65901ae37600%26elqaid%3D5709%26elqat%3D1%26elqCampaignId%3D425&tm=gtmv2&cookiesTest=true&liSync=true&e_ipv6=AQLpDd5wQM1eogAAAYr9zoewTirAl50dyoSwgFW74ZqicnQv1hRr7sf_WOIsSceGhh0j9FE
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Server: 13.107.42.14 , United States, ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Thu, 05 Oct 2023 03:08:05 GMT
x-li-pop: afd-prod-ltx1-x
x-msedge-ref: Ref A: 92798D826FA04F569C4542AD0C938BEB Ref B: FRAEDGE1313 Ref C: 2023-10-05T03:08:05Z
linkedin-action: 1
x-cache: CONFIG_NOCACHE
content-type: application/javascript
x-li-fabric: prod-ltx1
x-li-proto: http/2
content-length: 0
x-li-uuid: AAYG727GXxpeLVijqLmU8g==

Redirect headers

date: Thu, 05 Oct 2023 03:08:05 GMT
x-li-pop: afd-prod-ltx1-x
x-msedge-ref: Ref A: E5F1EB04FD674F518596A329670EA834 Ref B: FRAEDGE1718 Ref C: 2023-10-05T03:08:05Z
linkedin-action: 1
x-cache: CONFIG_NOCACHE
x-li-fabric: prod-ltx1
location: https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=4341164&time=1696475284671&url=https%3A%2F%2Fwww.citeline.com%2Fen%2Ftrialscope-intelligence%3Futm_campaign%3DCL-TSCOPEDISC-2309-Global-trialscope%2520intelligence-new%26utm_source%3DEloqua%26utm_medium%3DEmail%26utm_content%3D2023-09-Trialscope-Intelligence-Email2%26utm_term%3DExpert%2520insights%2520on%2520clinical%2520trial%2520disclosure%2520compliance%26elqTrackId%3DACA582E5838277658255B36B64FB5865%26elq%3D3440d3db64a641bda4bb65901ae37600%26elqaid%3D5709%26elqat%3D1%26elqCampaignId%3D425&tm=gtmv2&cookiesTest=true&liSync=true&e_ipv6=AQLpDd5wQM1eogAAAYr9zoewTirAl50dyoSwgFW74ZqicnQv1hRr7sf_WOIsSceGhh0j9FE
x-li-proto: http/2
content-length: 0
x-li-uuid: AAYG727B6tAriLiJ+N4l3A==

GET
H2 200 token Show response
cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/ 36 B
358 B 179ms
178ms XHR
application/json 2600:9000:206f:6c00:2:53b2:240:93a1
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://cdn.linkedin.oribi.io/partner/4341164/domain/citeline.com/token
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2600:9000:206f:6c00:2:53b2:240:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software: awselb/2.0 /
Resource Hash: 7b1eaaaf180a13c29b6dddc3b0ae23333b4397e0f3c065b4c86da2f2530a5f89

Request headers

Accept: *
Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

date: Mon, 02 Oct 2023 10:19:15 GMT
via: 1.1 e39402e2cf62b31f7774452c905f38f2.cloudfront.net (CloudFront)
server: awselb/2.0
x-amz-cf-pop: FRA56-C1
age: 233329
x-cache: Hit from cloudfront
content-type: application/json; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: *
cache-control: max-age=86400
content-length: 36
x-amz-cf-id: W4wAkEmZSUNqGD2v9NEOYYRJYdIfIEj6NiJTgpQEeMuPLWVarwNSNQ==

GET
H2 200 nr-spa-1.242.0.min.js Show response
js-agent.newrelic.com/ 83 KB
28 KB 133ms
39ms Script
application/javascript 151.101.130.137
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL

https://js-agent.newrelic.com/nr-spa-1.242.0.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

151.101.130.137 , United States, ASN54113 (FASTLY, US),

Reverse DNS

Software

AmazonS3 /

Resource Hash

f3d033242fbeee73edb343e177babbe82aa61b056a9d577c44adc3ca39e87789

Security Headers

Name	Value
Strict-Transport-Security	max-age=300

Request headers

accept-language: de-DE,de;q=0.9
Referer: https://www.citeline.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36

Response headers

x-amz-version-id: NIY1F_WlWVS2R9mNr6a1aamY5YcKaOJg
content-encoding: br
via: 1.1 varnish
date: Thu, 05 Oct 2023 03:08:05 GMT
strict-transport-security: max-age=300
x-amz-request-id: QK8QZ3YGA7HMYZN7
x-amz-server-side-encryption: AES256
x-cache: HIT
cross-origin-resource-policy: cross-origin
content-length: 28141
x-amz-id-2: 4zwT7MGIdSWZ/1FrM/o0cK+/bh+Ubewwy2YCJyD6vGpd8U161tCnh/zZE9f9V8l6MwAxwfqd1YA=
x-served-by: cache-fra-eddf8230037-FRA
last-modified: Tue, 26 Sep 2023 03:02:38 GMT
server: AmazonS3
x-timer: S1696475286.919271,VS0,VE0
etag: "5660bf51ffe3ae3573b4457eee221ad0"
vary: Accept-Encoding
content-type: application/javascript
access-control-allow-origin: *
cache-control: public, max-age=7200, stale-if-error=604800
accept-ranges: bytes
x-cache-hits: 101

POST
H/1.1 200
OK NRJS-63023392fa32fece2ad Show response
bam.eu01.nr-data.net/1/ 40 B
461 B 455ms
49ms XHR
text/plain 185.221.87.23
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://bam.eu01.nr-data.net/1/NRJS-63023392fa32fece2ad?a=471436775&v=1.242.0&to=MhBSZQoZXENUWxJYXwtafWc7V2FZQV0FXkIANl9fDApdXFldFB55CxFVSQ%3D%3D&rst=4151&ck=0&s=09e6e69225f9c42a&ref=https://www.citeline.com/en/trialscope-intelligence&af=err,xhr,stn,ins,spa&ap=76&be=720&fe=3271&dc=765&perf=%7B%22timing%22:%7B%22of%22:1696475281817,%22n%22:0,%22dn%22:1,%22dne%22:22,%22c%22:22,%22s%22:62,%22ce%22:108,%22rq%22:108,%22rp%22:720,%22rpe%22:817,%22di%22:1485,%22ds%22:1485,%22de%22:1485,%22dc%22:3989,%22l%22:3989,%22le%22:3991%7D,%22navigation%22:%7B%7D%7D&fp=1491&fcp=1491
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 185.221.87.23 , Ireland, ASN54113 (FASTLY, US),
Reverse DNS
Software: istio-envoy /
Resource Hash: 24c98b3653a1a89489a370d23ab35375bba6bf386f5c2cf8a34f59f1ee7ab2ee

Request headers

Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36
content-type: text/plain

Response headers

date: Thu, 05 Oct 2023 03:08:06 GMT
server: istio-envoy
access-control-allow-methods: GET, POST, PUT, HEAD, OPTIONS
content-type: text/plain
access-control-allow-origin: https://www.citeline.com
access-control-allow-credentials: true
x-envoy-upstream-service-time: 3
cross-origin-resource-policy: cross-origin
Connection: keep-alive
Content-Length: 40
x-served-by: cache-fra-eddf8230048-FRA

POST
H/1.1 200
OK NRJS-63023392fa32fece2ad Show response
bam.eu01.nr-data.net/resources/1/ 36 B
353 B 52ms
51ms XHR
text/plain 185.221.87.23
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://bam.eu01.nr-data.net/resources/1/NRJS-63023392fa32fece2ad?a=471436775&v=1.242.0&to=MhBSZQoZXENUWxJYXwtafWc7V2FZQV0FXkIANl9fDApdXFldFB55CxFVSQ%3D%3D&rst=4629&ck=0&s=09e6e69225f9c42a&ref=https://www.citeline.com/en/trialscope-intelligence&st=1696475281817&hr=0&fts=1696475281817&n=26
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 185.221.87.23 , Ireland, ASN54113 (FASTLY, US),
Reverse DNS
Software: /
Resource Hash: 2b09b35c12adf63c410ab2470b0d886e543c87ca2c45a3849b41a7a7448bc122

Request headers

Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36
content-type: text/plain

Response headers

date: Thu, 05 Oct 2023 03:08:06 GMT
access-control-allow-methods: GET, POST, PUT, HEAD, OPTIONS
content-type: text/plain
access-control-allow-origin: https://www.citeline.com
access-control-allow-credentials: true
Connection: close
Content-Length: 36
x-served-by: cache-fra-eddf8230048-FRA

POST
H/1.1 200
OK NRJS-63023392fa32fece2ad Show response
bam.eu01.nr-data.net/events/1/ 24 B
345 B 123ms
45ms XHR
image/gif 185.221.87.23
FASTLY

General

Check archive.org

Show headers Download Go to

Full URL: https://bam.eu01.nr-data.net/events/1/NRJS-63023392fa32fece2ad?a=471436775&v=1.242.0&to=MhBSZQoZXENUWxJYXwtafWc7V2FZQV0FXkIANl9fDApdXFldFB55CxFVSQ%3D%3D&rst=4687&ck=0&s=09e6e69225f9c42a&ref=https://www.citeline.com/en/trialscope-intelligence&ptid=db3096ff-0001-bc07-41f3-018afdce8bca
Requested by: Host: www.citeline.com
URL: https://www.citeline.com/en/trialscope-intelligence?utm_campaign=CL-TSCOPEDISC-2309-Global-trialscope%20intelligence-new&utm_source=Eloqua&utm_medium=Email&utm_content=2023-09-Trialscope-Intelligence-Email2&utm_term=Expert%20insights%20on%20clinical%20trial%20disclosure%20compliance&elqTrackId=ACA582E5838277658255B36B64FB5865&elq=3440d3db64a641bda4bb65901ae37600&elqaid=5709&elqat=1&elqCampaignId=425
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_128_GCM
Server: 185.221.87.23 , Ireland, ASN54113 (FASTLY, US),
Reverse DNS
Software: /
Resource Hash: 0c9cf152a0ad00d4f102c93c613c104914be5517ac8f8e0831727f8bfbe8b300

Request headers

Referer: https://www.citeline.com/
accept-language: de-DE,de;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/117.0.5938.132 Safari/537.36
content-type: text/plain

Response headers

date: Thu, 05 Oct 2023 03:08:06 GMT
access-control-allow-methods: GET, POST, PUT, HEAD, OPTIONS
content-type: image/gif
access-control-allow-origin: https://www.citeline.com
access-control-allow-credentials: true
Connection: keep-alive
Content-Length: 24
x-served-by: cache-fra-eddf8230053-FRA

Verdicts & Comments Add Verdict or Comment

67 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

17 Cookies

Cookies are little pieces of information stored in the browser of a user. Whenever a user visits the site again, he will also send his cookie values, thus allowing the website to re-identify him even if he changed locations. This is how permanent logins work.

Domain/Path	Expires	Name / Value
www.citeline.com/	1970-01-20 15:24:40	Name: AWSALB Value: lLyMonAkZwP4SeouVrhNCgocEhe6p2oeZu/J15XvqoX2FZK4ZlTQz59bAwn9sbyfF0pvVRNFl+6L7Isrl+wzHnJNoq6IV2wMtD2W5V2g3tXCWcVUO/fuJeusJuUO
www.citeline.com/	1970-01-20 15:24:40	Name: AWSALBCORS Value: lLyMonAkZwP4SeouVrhNCgocEhe6p2oeZu/J15XvqoX2FZK4ZlTQz59bAwn9sbyfF0pvVRNFl+6L7Isrl+wzHnJNoq6IV2wMtD2W5V2g3tXCWcVUO/fuJeusJuUO
www.citeline.com/	1969-12-31 23:59:59	Name: citeline#lang Value: en
www.citeline.com/	1969-12-31 23:59:59	Name: shell#lang Value: en
www.citeline.com/	1969-12-31 23:59:59	Name: ASP.NET_SessionId Value: xzwvsjmjcbzbwcdu1sb53t1b
www.citeline.com/	1969-12-31 23:59:59	Name: __RequestVerificationToken Value: VI_G6rai4katGgywLo4G3-JWz1qROHr-bYVtaqYhHhHl-k5dfzTNaN7CeG7jqy2eGa7vtVqSSCsBQUaV45PKE3FHk8M3uoINvompWX_kRMI1
.citeline.com/	1970-01-20 17:24:11	Name: _gcl_au Value: 1.1.991861437.1696475284
.citeline.com/	1970-01-20 17:24:11	Name: _fbp Value: fb.1.1696475283609.1962404572
.citeline.com/	1970-01-20 19:33:47	Name: OptanonConsent Value: isGpcEnabled=0&datestamp=Thu+Oct+05+2023+05%3A08%3A04+GMT%2B0200+(Central+European+Summer+Time)&version=202307.1.0&browserGpcFlag=0&isIABGlobal=false&hosts=&consentId=85f682d0-6ca6-4e1c-8073-761b9cf8fbf5&interactionCount=0&landingPath=https%3A%2F%2Fwww.citeline.com%2Fen%2Ftrialscope-intelligence%3Futm_campaign%3DCL-TSCOPEDISC-2309-Global-trialscope%2520intelligence-new%26utm_source%3DEloqua%26utm_medium%3DEmail%26utm_content%3D2023-09-Trialscope-Intelligence-Email2%26utm_term%3DExpert%2520insights%2520on%2520clinical%2520trial%2520disclosure%2520compliance%26elqTrackId%3DACA582E5838277658255B36B64FB5865%26elq%3D3440d3db64a641bda4bb65901ae37600%26elqaid%3D5709%26elqat%3D1%26elqCampaignId%3D425&groups=C0001%3A1%2CC0002%3A0%2CC0004%3A0
www.citeline.com/	1970-01-20 15:16:01	Name: ln_or Value: eyI0MzQxMTY0IjoiZCJ9
.linkedin.com/	1970-01-20 17:24:11	Name: li_sugr Value: d5616c8f-69fb-42fa-96be-9b18dc329e76
.linkedin.com/	1970-01-21 00:00:11	Name: bcookie Value: "v=2&73b21d1d-4c1d-4a9e-85eb-244935ddb96c"
.linkedin.com/	1970-01-20 15:16:01	Name: lidc Value: "b=TGST09:s=T:r=T:a=T:p=T:g=2595:u=1:x=1:i=1696475284:t=1696561684:v=2:sig=AQE4mRy8jviZnLrsVcGUGTuX-AHWL2TV"
.linkedin.com/	1970-01-20 15:57:47	Name: UserMatchHistory Value: AQJVEotIy3uHTwAAAYr9zoYvNjcZ--cHVrO-Mo28tCqFy9ckQ1rxP6lk03G0PhKshGzGjLnvC7gfJA
.linkedin.com/	1970-01-20 15:57:47	Name: AnalyticsSyncHistory Value: AQIHBBFKd4QlsAAAAYr9zoYv5S0YNNOM1nbGKHHAh8zHOY2PmtQNhDuPccCNyZfD_IP293A1D5vipfpaQlYojQ
.www.linkedin.com/	1970-01-21 00:00:11	Name: bscookie Value: "v=1&2023100503080554d16e51-b108-4b86-8af7-e8477dd365bbAQFWg_EFDAHqsgOPMfhvxCtLLvnlQY_r"
.linkedin.com/	1970-01-20 19:33:47	Name: li_gc Value: MTswOzE2OTY0NzUyODU7MjswMjFD7j+8rztPtIQLtp66CzHSlg39QJIdSN6RNoY2e2P8UA==

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header	Value
X-Frame-Options	SAMEORIGIN

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

bam.eu01.nr-data.net
cdn.cookielaw.org
cdn.linkedin.oribi.io
connect.facebook.net
edge.fullstory.com
fonts.gstatic.com
geolocation.onetrust.com
images.info.citeline.com
img06.en25.com
js-agent.newrelic.com
px.ads.linkedin.com
px4.ads.linkedin.com
rs.fullstory.com
snap.licdn.com
www.citeline.com
www.facebook.com
www.google.com
www.googletagmanager.com
www.gstatic.com
www.linkedin.com
13.107.42.14
151.101.130.137
184.25.216.9
185.221.87.23
23.53.43.147
2600:9000:206f:6c00:2:53b2:240:93a1
2606:4700:4400::ac40:9b77
2606:4700::6812:12aa
2606:4700::6812:83ec
2620:1ec:21::14
2a00:1450:4001:828::2003
2a00:1450:4001:82b::2003
2a00:1450:4001:830::2008
2a00:1450:4001:831::2004
2a02:26f0:3500:16::215:149b
2a03:2880:f083:9:face:b00c:0:3
2a03:2880:f176:84:face:b00c:0:25de
35.186.194.58
35.201.112.186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www.citeline.com Open in urlscan Pro 2606:4700::6812:12aa Public Scan

Summary

urlscan.io Verdict: No classification

Domain & IP information

Screenshot Live screenshot Full Image

Page Title

Detected technologies

Page Statistics

149 Requests

99 %HTTPS

63 %IPv6

15 Domains

20 Subdomains

19 IPs

3 Countries

3563 kBTransfer

7315 kBSize

17 Cookies

9 Outgoing links

Redirected requests

149 HTTP transactions Everything HTML Script AJAX CSS Image Expand all 2 data transactions

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

www.citeline.com Open in urlscan Pro
2606:4700::6812:12aa Public Scan

Screenshot
Live screenshot

Full Image

149
Requests

99 %
HTTPS

63 %
IPv6

15
Domains

20
Subdomains

19
IPs

3
Countries

3563 kB
Transfer

7315 kB
Size

17
Cookies

149 HTTP transactions
2 data transactions